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ABSTRACT
The field of tissue engineering has developed to try and find an alternative
approach to treat lost or damaged tissue. The field of tissue regeneration aims to develop
tissue scaffolds composed of biomaterials, a cell source, and appropriate
biochemical/phsysiochemical stimuli to replace current therapies. Stem cells offer great
promise due to their self-renewal capabilities and their numerous differentiation
possibilities. However, stem cells are extremely sensitive to their external environment
which presents a challenge when culturing them on biomaterials. Surface elasticity,
topography, surface chemistry, and exposure to biomolecules all represent environmental
stimuli that could affect stem cell behavior. This research aims to help bridge the gap
currently associated with tissue engineering by gaining a better understanding of how
these biomaterial properties influence stem cell fate. A tailorable poly(ethylene glycol)
dimethacrylate (PEGDMA) hydrogel will be utilized along with adult stem cells. It is
hypothesized that PEGDMA hydrogels that have an elasticity, architecture, and surface
chemistry more closely mimicking the extracellular matrix of the natural tissue
environment, will enhance stem cell differentiation towards a desired cell lineage (i.e.
bone, muscle, etc.). The project will look at different extracellular cues of a PEGDMA
hydrogel biomaterial and analyze how they affect stem cell differentiation. Through a
better understanding of cell-environment interactions the research from this project will
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help lead to the development of a tailorable tissue scaffold for tissue regeneration
purposes that can be manufactured on a large scale.
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INTRODUCTION AND SPECIFIC AIMS

1.1

Introduction

Regenerative medicine is a rapidly growing interdisciplinary field that aims to
repair, replace, or enhance cell, tissue, or organ function through clinically applicable
procedures.1,2 In most cases, successful regeneration of tissue requires the use of a
biomaterial scaffold to serve as the framework for cells to develop into functional tissue.
The development of scaffolds composed of materials with optimal chemical and physical
properties, adequate cell sources, and appropriate biochemical or biophysical cues – i.e.
biomimetic, is a vital aspect of the research in the field.3 Professionals in this field utilize
biomaterials, biochemical factors, biophysical stimulation, cell sources, or a combination
of many of these factors, to create therapies for a wide variety of applications.4,5
Repairing or replacing damaged tissues and organs, wound healing, degenerative diseases
such as muscular dystrophy, congenital conditions like diabetes, and stem cell based
therapies are all areas of research that are encompassed under the theme of regenerative
medicine.6–10 The potential cures and treatments that could emerge from regenerative
medicine research continues to drive the field forward.
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1.1.1

Tissue Engineering and Regenerative Medicine
Tissue engineering is a relatively new area of research, as the term “tissue

engineering” was coined in 1987 at a National Science Foundation meeting.1 Tissue
engineering developed from the field of biomaterials and according to the NIH can be
defined as “the practice of combining scaffolds, cells, and biologically active molecules
into functional tissues”.11 Tissue engineering has grown and is now considered its own
field of research and is in and of itself a multidisciplinary field that is often used
interchangeably with regenerative medicine.11 The basis for tissue engineering (Figure
1-1) is a scaffold with biomimetic properties including the proper biocompatibility,
degradation properties, mechanical properties similar to the innate tissue, and architecture
similar to that found in the body.12,7

Biomaterials

Biochemical/
Cell Source

Physiochemical
Cues

Figure 1-1: Diagram depicting the relationship of materials, cells, and extracellular
cues in tissue engineering. Tissue engineering in a multidisciplinary field that requires
biomaterials with appropriate mechanical properties, clinically relevant cell sources,
and adequate chemical or physical stimuli.

5
Skin replacement therapy research gained popularity in the 1990’s and became
the first engineered tissues.1,9 This research led to commercially available skin
replacements that aided in severe burn cases, reconstructive surgeries, and diseases that
led to skin necrosis.13,14 Advances in engineered skin therapies led to utilizing tissue
engineering scaffolds for potential therapies in chronic wound healing.7
Many have hope that tissue engineering will eventually lead to bioengineered
organs or at the very least, scaffolds that could stimulate tissue repair and restore function
in the damaged areas.6,15 Optimistically, advances in tissue engineering could eliminate
the need for organ transplants, which is currently the treatment option for end-stage organ
failure.6 There is a critical shortage of organ donors, which leads to thousands of
individuals without any course of treatment and reduces their life expectancy. According
to the United Network for Organ Sharing (UNOS), as of December 2019, 113,288
patients are currently waiting for a lifesaving organ transplant (Figure 1-2).16 In contrast,
there have only been 11, 876 donors from January-November 2019.16

Figure 1-2: Infographic on the need for alternative tissue replacement therapies.
Statistics showing the growing need for the creation of organs and tissue to address
the organ donor shortage.17
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Despite the drastic need for engineered organs, the process of creating fully
functional organs in a laboratory setting is extremely complex. Beyond just creating a
scaffold in the shape of an organ it must provide vascularization, signaling molecules,
and be able to interact with surrounding tissue to be physiologically relevant.18 There are
hundreds of researchers working around the world19 on the creation of fully functional
engineered organs such as bladders,20 lungs,21 and hearts.22
While this field still faces quite a few challenges, materials scientists, engineers,
and cell biologists continue working diligently to advance the field. A wide variety of
materials and cell sources have been utilized to create scaffolds for tissue regeneration.
There are three main classes of biomaterials used for creating tissue scaffolds: ceramics,
synthetic polymers, and natural polymers because of their mechanical stability,
tailorability, and biodegradability respectively.12,23 Ceramics and ceramic composites are
most commonly used in engineering of bone deformations, repair, or replacement due to
their high mechanical strength, ability to fuse with bone, and degradation properties.12,24
Hydroxyapatite (HA), calcium phosphate, argonite, bioactive glass, and tetracalcium
phosphate are a few of the ceramic materials that have been explored for tissue
repair/replacement.25–30 Numerous synthetic polymers have been and continue to be
investigated for a wide variety of therapeutic applications in tissue engineering. A few,
but certainly not all of those used, include polymers such as polylactic acid (PLA),
polyglycolic acid (PGA), polycaprolactones, polycarbonates, poly(ethylene) glycol
(PEG), and poly(2-hydroxyethyl methacrylate-co-methacrylic) (pHEMA).12,29,31–35 Tissue
engineering also relies heavily on natural polymeric scaffolds including collagen, elastin,
silk, fibronectin, alginate, hyaluronan, chitosan, gelatin, and chondroitin sulfate for
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scaffold development.12,31,32,35–38 More on synthetic polymers will be discussed in
Chapter 2.
Advances in the field of tissue engineering have occurred in parallel with
innovations in stem cell research as stem cells provide a source of self-renewing,
multipotent cells for autologous treatments. The cellular component of tissue constructs is
arguably one of the most challenging aspects. The cell source is one consideration that
must be evaluated. Cells can be autologous, meaning from the patient themselves,
allogenic, which are donor cells from another individual, or xenogeneic, which come
from another species altogether.39 The type of cell, mainly primary or stem cells, used
will also influence the function of the scaffold. Primary cells are fully differentiated cells
that are harvested from tissue-specific locations.40 Stem cells retain self-renewal
capabilities and have the ability to differentiate into multiple different cell types.41 The
determination of which cell type is better suited will vary from application to application.
Primary cells will be the most compatible immunologically and will be fully
differentiated so the environment will not influence the type of tissue being formed
although typically yields are low.40 Stem cell are found abundantly in the body, however,
they are sensitive to their chemical and physical environment which can lead to changes
in predicted cell behavior and alter cell fate.42 Multipotent stem cells, such as human
adipose stem cells (hASCs) offer the most promise in cell-based regenerative therapies
due to their self-renewal capabilities, and ability to differentiate into cells found in
mesoderm tissues such as myoblasts, adipocytes, osteoblasts, and chondrocytes, and can
easily be harvested from patients. More specifics on stem cells used for regenerative
medicine applications will be presented in Chapter 2.
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1.1.2

Challenges Facing Tissue Engineering
Even with the need and ever-growing popularity of tissue engineering andall the

advances made thus far, there is still a long way to go to reach reliable clinical
application. Every case where tissue engineering and regenerative medicine offers hope,
there will be unique and diverse challenges.5 Each case will be unique in terms of injury,
severity of condition, inflammation, natural tissue remodeling, age, and degeneration,
complicating treatment. Some cases will require materials with high mechanical stability,
such as bone tissue engineering, while other injuries will need softer, more elastic
materials to mimic the extracellular matrix.43 Constructs can either be degradable, which
means the scaffold dissipates over a period of time, or they can be non-degradable so the
scaffold is permanent. One example of where a degradable scaffold would be
advantageous is for wound healing applications. The scaffold could be utilized to
promote healing and recruit cells to repair the tissue and degrade over time leaving only
healthy tissue in its place.44 Permanent scaffolds would be advantageous in whole organ
replacement to provide a stable platform for new tissue, cells and vascularization to
incorporate into. With the complexity of these issues, no one approach will be the
answer. Instead, it will likely be an approach of different materials, cell sources, and
techniques that offer solutions.9
For these constructs to be successful they should be analogous to the natural
environment of the extracellular matrix (ECM) niche in which they will be implanted.45
For this reason, hydrogel-based materials are of particular interest in creating tissue
scaffolds due to their biocompatibility, capability to retain large amounts of water, innate
biomimetic properties, and the minimal tendency to adsorb proteins from body fluids.46
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The challenge with using scaffolds for regenerative medicine lies in reproducibly
differentiating stem cells on these materials to desired lineages. Cell-microenvironment
interactions control vital cell processes such as proliferation, differentiation, and cell
migration.47 Despite the volume of research being conducted in this area, these
interactions between stem cells and the external environment created using biomaterial
substrates are not well understood.
1.2

Specific Aims

Previous work in our lab has synthesized poly(ethylene glycol) dimethacrylate
(PEGDMA) hydrogels on which mouse embryonic stem cells (mESCs), human bone
marrow-derived stem cells (hMSCs), and human adipose stem cells (hASCs) were
successfully seeded.48 Cell viability assays confirmed that each cell type was able to
remain viable on the PEGDMA hydrogel platform. In addition, quantitative reverse
transcriptase polymerase chain reaction (qRT-PCR) of multipotent and pluripotent
markers demonstrated that the cells retain their multipotent and pluripotent state. It was
also shown that the PEGDMA hydrogels could be synthesized to have different elastic
moduli by varying the percentage and molecular weight of the polymer.48 My Ph.D.
project has focused on expanding this research by investigating how extracellular cues
specifically, cell culture material elasticity and surface chemistry influence stem cell fate.
The specific aims for this project were:
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1) Evaluate the Influence of Hydrogel Elasticity on Stem Cell Fate
2) Evaluate the Effects of Post-processing Drying Methods on PEG Based
Hydrogels
3) Evaluate the Influence of Biochemical Cues on Myogenic Differentiation of
hASCs
Upon completion of this project a better understanding of environmental influence on
stem cell fate as well as procedures for more efficiently directing myogenic
differentiation of hASCs will be gained.
1.2.1

Specific Aim 1: Evaluate the Influence of Hydrogel Elasticity on Stem Cell

Fate
The goal of Aim 1 was to investigate the interactions between an elastically
tailorable polyethylene glycol (PEG)-based hydrogel platform and human bone marrowderived mesenchymal stem cells (hMSCs). For these studies, poly (ethylene glycol)
dimethacrylate (PEGDMA) hydrogels of two varying elasticities were utilized; “soft
hydrogels” (8-10 kPa) and “stiff hydrogels” (50-60 kPa). These two PEGDMA hydrogel
blends were then surface functionalized with the ECM protein fibronectin. Human MSCs
were then seeded on each hydrogel blend as well as tissue culture plate controls. The
effect of varying hydrogel elasticity on hMSC attachment, multipotency, proliferation,
and differentiation towards osteogenic and adipogenic lineages was then examined. By
evaluating the attachment, proliferation, multipotency, and differentiation potential of
hMSCs cultured on soft hydrogels, stiff hydrogels, and tissue culture plates we are able to
determine if PEGDMA hydrogel elasticity influences stem cell fate.
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1.2.2

Specific Aim 2: Evaluate the Effects of Post-processing Drying Methods on

PEG Based Hydrogels
The goal of Aim 2 was to create a PEGDMA hydrogels with multiscale porosity
with suitable properties for stem cell culture that could be used to further investigate the
influence spatial configuration has on stem cell fate. Varying blends and thicknesses of
PEGDMA hydrogels were synthesized, flash frozen, and dried by lyophilization to create
scaffolds with multiscale porosity. Air-dried hydrogels of varying thickness were used as
a control for comparison. Environmental scanning electron microscopy (ESEM) was
utilized to visualize changes in hydrogel morphology in a dry state as well as in their
hydrated state. Equilibrium swelling studies were conducted to evaluate changes in
swelling behavior as well as used to calculate the average pore size diameter of hydrogels
of varying blend, thickness, and drying method.
Rheology data was also obtained to find the shear elastic modulus of each
PEGDMA blend of varying thickness and drying method. The shear elastic modulus will
help to determine which hydrogel blend may be most appropriate for tissue engineering
applications. In addition, all combinations of hydrogel blend, thickness, and drying
method were subjected to a series of solutions they would be exposed to if used for stem
cell culture as to analyze degradation properties. Cell viability and morphology was also
evaluated to confirm the potential use of these scaffolds for stem cells and tissue
engineering applications.
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1.2.3

Specific Aim 3: Evaluate the Influence of Biochemical Cues on Myogenic

Differentiation of hASCs
The goal of Aim 3 was to expand on previous differentiation work by inducing
myogenic differentiation of hASCs using myogenic differentiation media recipes that
contain different biochemical factors that have been reported in the literature.49,50 While
several groups have shown that hASCs have the potential to differentiate towards a
myogenic lineage,49–51 there is no universal myogenic differentiation media.52 Therefore,
there is a need to determine the optimal myogenic media for hASC differentiation.
Optimization of differentiation involved the culturing of hASCs on standard
polystyrene tissue culture plates for different time points. The hASCs were cultured in 3
different medias for up to 6 weeks. RNA was then collected and reverse transcriptasepolymerase chain reaction (RT-PCR) was performed to evaluate gene expression of
common myogenic genes. Immunofluorescence to examine MYOD and myosin protein
expression and localization was also utilized to further validate myogenic differentiation.
All assays were completed in triplicate to allow for analysis of statistical significance.
Human skeletal myoblasts (HSkMs) were used as a positive control for RT-PCR and
immunofluorescence.
Optimizing myogenic differentiation of hASCs by controlling the exposure to
biochemical factors in tissue culture will allow for the progression of the project in
determining how extracellular cues of PEGDMA hydrogel biomaterials influence stem
cell fate. At the completion of this aim we will have not only a reliable media recipe for
differentiation of hASCs, we will also have a set of assay protocols in place to allow for
efficient characterization of myogenesis in future experiments.
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1.3

Overview

In the subsequent chapters the background and significance of this research which
focuses on creating a better understanding of how the extracellular cues provided by
PEGDMA hydrogel biomaterials influences stem cell fate, will be presented.
Understanding the dynamic interactions between cells and materials is the first step in
producing innovative and adaptable hydrogel biomaterials to advance the clinical
potential of cell-based regenerative therapies. This will allow for the creation of more
reproducible, efficient, and tailorable scaffolds to be used in clinically repairing and
replacing lost and damaged tissue. The background and more in-depth discussion of stem
cells, hydrogels, and significance of work such as this is presented in Chapter 2.
Following the presentation of background information, Chapter 3 will focus on
investigating the influence that PEGDMA hydrogel elasticity has on hMSC fate and
compared to tissue culture controls. This work was published in the Oxford Academic
journal Regenerative Biomaterials in April of 2018. Chapter 4 will focus on the
development of PEGDMA hydrogels with multiscale porosity for tissue engineering
applications through the use of freeze-dry lyophilization. The work presented in Chapter
4 was published by Taylor and Francis in the Journal of Biomaterials Science, Polymer
Edition in July of 2019. In Chapter 5 data collected while optimizing myogenic
differentiation of hASCS through a combination of cell culture medias, ECM proteins,
and a DNA methylation inhibitor will be presented and demonstrate the most efficient
method to promote myogenic differentiation in hASCs. This work is being prepared for
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submission to Journal of Experimental Biology. Finally, Chapter 6 will focus on project
conclusions, future directions, and the significance of the results from this research.

BACKGROUND

2.1

Overview of the Extracellular Matrix

Cells are highly sensitive to their surroundings with hundreds of different proteins
having a role in stimulating cell receptors, which in turn determines numerous responses.
This highly defined and specialized cell microenvironment, which is essential for tissue
development and function, is the extracellular matrix (ECM).53,54 The extracellular
microenvironment surrounds cells and is a highly hydrated network that contains
molecular signals.55 The ECM is composed of a variety of molecules (Figure 2-1)56
including members of the collagen family, elastic fibers, glycosaminoglycans (GAGs),
proteoglycans, and adhesive glycoproteins.53
The ECM can effect cell behavior by directly regulating cell functions through
receptor-mediated signaling, and this network can control the mobilization of growth
factors or differentiation factors.53 This means that the ultimate decision for a cell to
differentiate, proliferate, migrate, apoptose, or perform other functions, is a coordinated
response to the molecular interactions with these ECM effectors.55
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Figure 2-1: An illustration of the extracellular matrix. Visual representation of the
extracellular matrix depicting some of the major protein components.56
2.1.1

Challenges for Tissue Engineering
For a tissue scaffold to be successful it must support the formation of tissue-

relevant mimics, as well as promote cell adherence, cell migration, foster transport of
nutrients and waste, and form new extracellular matrix.57 Since the ECM is critical in cell
proliferation and differentiation, tissue engineering approaches usually utilize exogenous
three-dimensional ECM’s to engineer new tissues from isolated cells.58 Synthetic ECMs
should facilitate the localization and delivery of cells to specific sites in the body,
maintain a 3D space for the formation of new tissues, and guide the development of new
tissues with appropriate functions.53,58,59 Synthetic ECMs need a large surface-to-volume
ratio to allow for a high density of cells. Since the ECM varies in different tissues and at
different stages of development, choosing the appropriate mechanical and degradative
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properties is important.54 The cells that compose the engineered tissue need to express
appropriate genes so that the cells maintain tissue-specific function. The function of
seeded cells is dependent upon the specific cell-surface receptors used by cells to interact
with the material, interaction with surrounding cells, and on the presence of growth
factors.53 This can be controlled by incorporating cell-adhesion peptides or growth factors
into the synthetic ECM or by subjecting the synthetic ECM to mechanical stimuli.53,58
Therefore, the biomaterial used in tissue engineering plays an important role as it can
serve as a substrate for attachment, be used as a cell delivery vehicle, and activate
specific cellular functions in localized regions.60
The chemical and spatial configuration of surfaces on which cells grow also plays
a key role in controlling cell behavior. Properties like those of surface topography or
spatial conformation, hydrophobicity, and specific interactions of a material with a cell
surface can affect the cells activity.61 The surface properties of a biomaterial also
determine which biomolecules will adsorb.62 In the ECM cells interact with nanoscale
topographical features that vary in size and composition. The topography can affect cells
in terms of adhesion, morphology, migration, proliferation, cytoskeletal arrangement, and
gene expression.63–65 Different surface treatments can be used to modify the topography
and surface chemistry of the biomaterials to improve adhesive interactions with cells.62,66
The energy at the surface with a net positive or negative charge is more likely to be
hydrophilic, whereas a surface with a neutral charge is likely to be more hydrophobic.
The surface energy of the material can influence which proteins adhere to the biomaterial.
Therefore, the changes in hydration can change the behavior of adsorbed proteins.62 To
achieve more biomimetic biomaterials, the surfaces of materials have been modified to
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include bioactive molecules. Biomaterials can be coated with ECM proteins to promote
cell adhesion, proliferation, and differentiation.60 These modifications make the material
mimic the ECM more closely, which in turn makes it a more viable tissue scaffolding
option.
The ECM structure also provides spatial control that can promote cell-to-cell
communication. Contact-dependent, cell-cell signaling (juxtacrine signaling) provides
constant morphogenic cues, while the diffusion of soluble signals from neighboring cells
(paracrine signaling) transiently affects proximal populations of cells. These interactions
between cell populations influence a range of stem cell behavior including the induction
of programs of differentiation67 and self-renewal properties.68–71 Positioning within the
stem cell microenvironment, achieved by the spatial distribution of the ECM and cell-cell
contacts, physically confines stem cell self-renewal and differentiation behavior by
guiding the position of the mitotic axis in asymmetric division.72,73
Superimposed on all of these mechanisms, is the mechanical environment (Figure
2-2) that governs ECM interactions, changes sensitivities to soluble cues and physically
alters cell populations within tissues. The mechanical environment influences all aspects
of tissue behavior, since the majority of all cells require interaction with the ECM to
maintain viability. Adherence allows cell to exert contractile forces on their environment
and sense compliancy to induce appropriate cellular behavior.74 Research in the area has
demonstrated that 2D substrates with mechanical properties that match native tissue
(neuronal, muscle, and bone) more efficiently promote mesenchymal stem cell
differentiation down specific lineages.75
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Figure 2-2: Elastic moduli of natural tissue. One important component of the
mechanical environment is the elasticity of tissue. Elasticity has been shown to affect
cell behavior, therefore material elasticity is an important component of tissue
engineering scaffolds. Image credit: Rachel Eddy. Adapted from Butcher et al.
200976

2.2

Brief Overview of Stem Cells

The knowledge gained from stem cell biology is paving the way for the
generation of unlimited cells of specific phenotypes to be incorporated into tissue
engineering constructs.40,77 Stem cells are undifferentiated and unspecialized cells that
retain the ability to differentiate into multiple cell lineages.40,77,78 (Figure 2-3) Stem cells
can be categorized based on their potency (totipotent, pluripotent, multipotent,
oligopotent, or unipotent).79
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Figure 2-3: A hierarchal structure showing the differentiation potential of stem cells
based on their potency. Totipotent stem cells have the most differentiation potential
while unipotent cells have limited differentiation potential into tissues they are found
in, and are fully committed to becoming that tissue.80

2.2.1

Totipotent Stem Cells
Totipotency is the ability to differentiate into embryonic and extra-embryonic

tissues.79 Totipotent cells represent the ability to form a whole functioning organism from
that one single cell.81 In humans, the zygote, which is produced from the fusion of an egg
and sperm cell, represents a totipotent cell.81 Only the zygote and their direct descendants
(referred to as morula stem cells) undergo symmetrical cell division and are the only
totipotent stem cells.79,81,82 Cells are classified as totipotent until at least the 4-cell
embryo stage and potentially until the 16-cell stage where they begin to further commit to
a more specified lineage.79,81
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2.2.2

Pluripotent Stem Cells
Pluripotency refers to the ability of cells to differentiate into the three germ

layers.79,81–83 However they do not contribute to extra-embryonic tissues such as the
placenta.79,84 These cells also retain an ability to proliferate indefinitely under the right
conditions.83–85 Pluripotent stem cells are descendants of totipotent cells and are naturally
found in the inner cell mass of embryos.81,83,85 There are two classes of pluripotent stem
cells: embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs).
Embryonic stem cells are those cells found in the inner cell mass during
embryogenesis.86 These cells fit the criteria of a pluripotent cell as they maintain their
self-renewal capability and can differentiate into all three germ layers.85 Mouse
embryonic stem cells were the first pluripotent cells to be isolated and cultured in vitro in
1981.87,88 and set the requirements for pluripotent stem cell classification. These critera
mandate that the cells
(1) originate from a pluripotent cell population
(2) have and maintain a normal karyotype
(3) be immortal
(4) be able to be propagated indefinitely in the embryonic state
(5) be capable of spontaneous differentiation into somatic cells of all three germ
layers79,86
Embryonic stem cells are also characterized by the expression of hallmark transcription
factors: Oct4, Sox2 and Nanog.84,85,89 These cells have increased plasticity in that they
can be more easily manipulated since they lack specific epigenetic modifications.78,90
Their indefinite undifferentiated proliferation in vitro with the potential to differentiate
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into any of the tissues found in a body gives them great promise for regenerative
medicine applications. However, the use of human embryonic stem cells for research has
been an ethical debate since their discovery.90 One such concern comes from the origin of
these stem cells. Human embryonic stem cells come from “pre-implantation” embryos,
with the majority coming from leftover IVF embryos that were donated.91 While
embryonic stem cell pluripotency is commonly seen as their biggest advantage, this
property can lead to the formation of teratomas. Teratomas are tumors that contain tissues
from all three germ layers,92 which poses a potential complication for translation into
human subjects. Human embryonic stem cells used for therapies would be of an allogenic
source, which increases the chances of eliciting an immune response since the donor cells
would not be immunologically identical to the recipient.93
Fortunately, an alternate pluripotent cell population for research was discovered
that in many ways could address the ethical concerns associated with embryonic stem
cells. In 2006 Kazutoshi Takahashi completely changed the stem cell field with the first
publication on induced pluripotent stem cells (iPSCs).94 For the first time, adult mouse
fibroblasts were reprogrammed using a retrovirus and the result was a cell line that
expressed the characteristics of mouse embryonic stem cells. It wasn’t long before the
research extended into human cells as well.95 These iPSCs meet all of the requirements
outlined for ESCs. 96 Now cells such as keratinocytes, T cells, fibroblasts, and cord blood
cells among others are being reprogrammed to produce iPSCs.2,79 Introduction of the
required transcription factors for reprogramming can be delivered though viruses,
proteins, plasmids, mRNAs, and other small molecules.2,79 Even more than 10 years after
the discovery of iPSC cells, they remain a complex and difficult cell type to expand and
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differentiate in culture.97,98 Even when using the same differentiation method to
reprogram cells there are varying levels of efficiency making it difficult to reproduce
results.99 The main concern with utilizing iPSCs is their epigenetic memory of the DNA
from the starting cell.90,100 The hope is that iPSCs could be engineered to be patient and
even disease specific torevolutionize regenerative medicine. 90
2.2.3

Multipotent Stem Cells
Multipotent stem cells are capable of self-renewal and differentiation into

multiple tissue types.101,102 However, their differentiation is limited in comparison to
totipotent and pluripotent stem cells. Often times they have finite self-renewal
capabilities as well.79 There are a variety of stem cells with multipotent properties
including bone marrow-derived mesenchymal stem cells, adipose-derived stem cells,
neural stem cells, mesenchymal cardiac-specific stem cells, fetal stem cells, amniotic
stem cells, placental stem cells, hematopoietic stem cells, endothelial stem cells, and
muscle-derived stem cells among others.79,101,103–106 While there are numerous types of
multipotent stem cells, this work will only focus on two populations of adult stem cells:
bone marrow-derived mesenchymal stem cells (MSCs) and adipose-derived stem cells
(ASCs).
Human bone marrow-derived MSCs and ASCs are adult, mesenchymal stem
cells. Mesenchymal stem cells are uncommitted, nonhematopoietic progenitor cells that
originate from mesoderm tissue and that can differentiate into multiple cell types under
the appropriate stimulus.107,108 These stem cells are found in the bone marrow, adipose
tissue, periosteum, synovial cartilage, and deciduous teeth.49,79,101,109 Mesenchymal stem
cells are attractive for tissue engineering due to their ability to differentiate into
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chondrocytes, osteocytes, adipocytes, fibroblasts, neural cells, or myoblasts based on
culture conditions and growth factors.107,110–112 Mesenchymal stem cells are also
characterized by their fibroblast-like morphology, expression of the surface markers CD
44, CD73, CD90, and CD105 and lack the expression of CD14, CD34, and CD45.79,107,113
In addition, adult mesenchymal stem cells have been found to have immunomodulatory
properties, making them excellent options for tissue engineering applications.79,114 Bone
marrow-derived MSCs and ASCs have the same basic properties that are characteristic of
all mesenchymal stem cells. However, there are a few key differences between these two
stem cell populations. As their names would suggest, bone marrow-derived MSCs are
harvested from bone marrow, while ASCs are harvested from adipose
tissue.79,101,107,113,115,116 Mesenchymal stem cells have finite life spans when cultured in
vitro.110 Studies have suggested that bone-marrow derived MSCs have a shorter culture
life compared to ASCs.8 In addition, while they are present throughout life, the
concentration of the population of bone marrow-derived MSCs is inversely related to the
age of the person.110,114 Meanwhile, with the rate of obesity in the world today adiposederived stem cells are readily available.101 Adipose-derived stem cells can be harvested in
greater quantities when compared to bone marrow-derived MSCs.8 Finally, the harvesting
of bone marrow-derived MSCs is also an invasive and painful procedure, whereas
lipoaspiration is minimally invasive.101,113 While both cell populations are viable
candidates for regenerative medicine applications, ASCs appear to hold more promise
due to their abundance and ease of collection.
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2.2.4

Oligopotent and Unipotent Stem Cells
Oligopotent stem cells retain the ability to self-renew and differentiate into a

limited number of lineages, typically two lineages.79,117 These cell are found in adults and
they differentiate into tissue specific lineages.117 Oligopotent stem cells have been found
on the ocular surface of mammals as well as in vascular tissue.79,118 Unipotent cells are
also referred to as precursor cells.79 Unipotent cells can only differentiate into one cell
type.117 A population of stem cells found in the epithelium give rise to new skin cells and
allows for skin to be grown in vitro for tissue grafts.79 While oligopotent and unipotent
stem cells play important roles in adults, they are not often utilized in tissue engineering
and regenerative medicine due to their limited differentiation potential.
While stem cells have the potential to be powerful tools in tissue repair and
regeneration, they are extremely complex cells. Not only do we have to understand the
background of the stem cell type of interest, but we also need understand how the
environment and growth factors affect differentiation. Combining these dynamic cells
with a hydrogel scaffold that could provide the optimal environment for specific
differentiation, is an attractive method to combat the need for tissues for repair and
regeneration.
2.3

A Brief Overview on Hydrogels

Hydrogels are an advantageous approach to tissue engineering due to their
chemical similarity to that of the extracellular matrix, their flexibility, rapid diffusion of
hydrophilic nutrients and metabolites, as well as their low content of dry mass, which
causes reduced irritation and much lower level of degradation products.119 These
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properties allow hydrogels to provide an environment that is similar to the ECM as well
as provide additional structural support. Synthetic, natural, and synthetic/natural hybrid
hydrogels are viable options for tissue engineering and appealing in their own ways.
2.3.1

Common Hydrogel Properties
Hydrogels were first introduced in 1960 by Wichterle and Lim when soft contact

lenses were created from a hydrophilic network of poly(2-hydroxyethyl methacrylate)
(pHEMA).46,120 Hydrogels are three-dimensional, cross-linked polymer networks that
tend to be very hydrophilic in nature.46,120–122 Their innate properties and tailorability
make them an attractive option for tissue engineering. Hydrogels tend to have
viscoelastic and diffusion properties similar to those found naturally in the extracellular
matrix (ECM).123 Advances in biomaterials has led to the development of hydrogels
made from numerous materials yielding a wide range of properties making it easier to
tailor hydrogels to mimic the target tissue (Figure 2-4).123 Depending on their chemical
composition, hydrogels have the potential to absorb up to thousands of times their dry
weight in water.46,120 The hydrophilicity of a hydrogel determines the absorption and
diffusion of solutes through the hydrogel, which can be crucial depending on their
application.120,122 The polymer networks of a hydrogel can be held together by hydrogen
bonds, ionic forces, primary covalent cross-links, bio-recognition interactions,
hydrophobic interactions, physical entanglements of polymer chains, polymer crystallites,
or a combination of these.46,120,124,125 There are different types of hydrogels that are
classified based on their preparation and synthesis, charge, mechanical, and structural
properties.46
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Figure 2-4: Graphical illustration of a hydrogel biomaterial. This figure illustrates the
crosslinked hydrogel network (middle insert) along with an illustration of cells seeded
onto the hydrogel surface (smallest callout). Image credit: Rachel Eddy.
Hydrogels can be composed of a number of different materials, all falling within
three categories: natural polymers, synthetic polymers, or a combination of the two
(semisynthetic) can be used in the formation of hydrogels.120,122 Based on the material
used and synthesis process hydrogels can be neutral in charge, cationic, anionic, or
ampholytic.124,126,127 Hydrogels may also be chemically stable and therefore permanent,
or they can eventually degrade depending on how they are designed.46 In addition, these
polymer networks can be designed to be responsive networks. Most commonly hydrogels
can be thermally-responsive, pH-responsive, and light-responsive.128,129 They can also be
sensitive to other environmental stimuli such as glucose, pressure, specific ions, enzymes
and specific antibodies.128 The highly tailorable nature of hydrogels is the drive behind
the widespread use as a biomaterial in areas of research such as drug delivery, wound
healing, agriculture, hygienic products, and tissue engineering.120,121,125,127,130,131
There are some limitations associated with hydrogels biomaterials. It is difficult to
sterilize the materials if it is from a natural polymer and this is an important step if a
material is to be implemented into the human body.120 In addition, while hydrogels tend
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to be biocompatible and many even bioinert, certain materials such as poly(ethylene
glycol) (PEG) do not promote cell adherence,an issue in tissue engineering and wound
healing.132 However, PEG is bio-stealth and does not elicit an immune response.130 Each
polymer interacts differently with cells and it is important to keep that in mind when
choosing a hydrogel composition. Hydrogel permeability can also be an issue dependent
on application. For migration of cells it is advantageous, but could cause issues with
controlled release of drugs or biomolecules.133 What is likely the biggest disadvantage to
hydrogels is their low mechanical strength.134 This makes the materials harder to handle
and limits how effective they will be in different environments in the body. Low
mechanical strength limits hydrogel efficiency for bone regeneration but is advantageous
for engineering soft tissues. Hydrogels can be composed of synthetic polymers, natural
polymers, or a hybrid of the two. A brief overview of synthetic polymers is in the
following sections. Overviews of natural and hybrid polymers is located in Appendix A.
2.3.2

Synthetic Hydrogels
Hydrogels composed of synthetic polymers are easier to reproduce and their

chemical make-up and properties can be controlled through the synthesis process.132 This
information is summarized in Table 2-1. Hydrogels composed of poly(Nisopropylacrylamide (PNIPAAm), poly(ethylene oxide) (PEO), polyvinyl alcohol (PVA),
poly(propylene fumarate-co-ethylene glycol) P(PF-co-EG) and polyphosphazenes are
commonly studied synthetic hydrogels for tissue engineering.119,132 PEO/PEG is currently
FDA approved for numerous medical applications, and is one of the most commonly used
synthetic hydrogels for tissue engineering.132,135 The main disadvantage of PEG is that
when it is formed into a triblock polymer, there is a lack of degradation.
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Table 2-1. An overview of synthetic polymers used in making hydrogel biomaterials.
Polymer

Disadvantages

Advantages

Lack of
biodegradation

FDA approved;
currently used in
numerous medical
applications; bioinert

Space filling and
drug delivery

Some formulations
are not dissolvable
in aqueous
solutions

Bio-inert; higher
mechanical strength
and flexibility;
hydroxyl groups to
attach
proteins/biological
molecules

P(PF-co-EG)

Injectable carrier
for bone and blood
vessel engineering

Homopolymer
(PPF) is
hydrophobic
polyester that
undergoes
degradation by
hydrolysis of the
ester linkage

Swelling ratios
characteristic of
highly crosslinked
polymers with
flexural moduli
similar to the aorta
suggesting promise
in blood vessel
engineering

PNIPAAm

Injectable delivery
mechanism for
cartilage and
pancreas
engineering

Nondegradable
cross-links; vinyl
monomers and
crosslinking
molecules are toxic,
carcinogenic, and
teratogenic

Inverse solubility
upon heating

Polyphosphazenes

Controlled delivery
of protein drug;
possibility of use in
skeletal tissue
regeneration or
encapsulation of
hyridoma cells

Lack of rigorous
reviews of material

Nontoxic, neutral
degradation
products

PEO/PEG

PVA

Uses

Many
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This lack of degradation can be altered if it is linked with a biocompatible
material that degrades well in the body.130,132 PVA has been used as a space filling agent
in tissue engineering as well as drug delivery. PVA is bio-inert and has ample hydroxyl
groups that allow for easy attachment of growth factors, proteins, or other biological
molecules.136 However, some formulations of PVA is not dissolvable in aqueous
solutions. Poly(PF-co-EG) has been shown to have a swelling ratio characteristic of
highly crosslinked polymers with flexural moduli similar to the aorta, suggesting promise
in blood vessel engineering.137 It has also been studied as an injectable carrier for bone
and blood vessel engineering.138 The homopolymer it is composed of, (PPF), is a
hydrophobic, linear polyester that undergoes degradation by hydrolysis of the ester
linkage.137 PNIPAAm has been studied as a delivery mechanism for cartilage and
pancreas tissue regeneration.132,139,140 PNIPAAm has also been used as a molecular
switch in thermoresponsive substrates due to its inverse solubility upon heating.140,141
Unfortunately, the vinyl monomers and cross-linking molecules are potentially toxic,
carcinogenic, and teratogenic.128 Polyphosphazenes have the potential to be beneficial in
skeletal tissue regeneration or for the encapsulation of hybridoma cells.132,139 With all
synthetic polymer hydrogels, there is always a slight chance of an immunogenic response
since a foreign substance has been implemented into the body. This is why it is crucial to
undergo in vitro and in vivo studies before implanting a scaffold of a substance with
unknown biocompatibility into humans for clinical use.
2.3.3

PEG Based Hydrogels
Poly(ethylene glycol) or PEG is one of the most commonly utilized polymers for

tissue engineering applications.132 As previously mentioned, PEG is synonymous with
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poly(ethylene oxide) (PEO), the only difference is the molecular weight being used.130
One attraction for using PEG and PEG-based materials is that PEG is FDA approved and
used in several medical applications.130,135,139 PEG is a non-toxic polymer that is soluble
in water as well as many organic solvents.130,135 This polymer has minimal protein and
cell adsorption so it is not recognized by the immune system and is therefore classified as
bioinert.31,121,130 It can also be rapidly cleared from the body.130 PEG hydrogels are easily
tailorable and can have a broad range in elasticity.121 Taken together, these properties
makes PEG-based hydrogels desirable when investigating the influence of material
elasticity, spatial configuration, and surface chemistry treatments because the PEG
hydrogels themselves are bioinert to cells. One notable feature of PEG is that when it is
crosslinked with another molecules, it can transfer its properties to that molecule (i.e.
make them non-toxic).130 The biocompatibility and physiochemical properties of PEG is
what makes this polymer and its derivates appealing for tissue engineering.130,132,135
2.3.4

Hydrogels in Tissue Engineering
Scaffolds for tissue engineering in many cases are used to initially fill a space that

would normally be occupied by natural tissue. The scaffold’s job is to provide the
framework so the tissue can be regenerated. The physical properties of the scaffold are
imperative for success. For hydrogels, the physical properties inherent to its success
includes the gel formation dynamics, mechanical properties and its degradation
behavior.132 The hydrogel formation dynamics can alter the hydrogel morphology,
structure, mechanical properties, and what cells, drugs, or biomolecules can be
incorporated.132,142 Hydrogels offer an exciting approach in that cells and molecules can
be mixed with the hydrogel precursor solution to be injected in vivo.143,144 The
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mechanical properties of the hydrogel can be controlled by the polymer composition, the
crosslinker type and density, swelling characteristics, and gelling conditions.43,48,125,145,146
The kinetics behind the hydrogel scaffold degradation will be dependent upon the tissue
engineering application. In an ideal scaffold, the hydrogel will degrade at a rate that
matches that of new tissue formation.132
The mass transport properties and biological properties of the hydrogel scaffold
are also important considerations in designing a tissue engineering scaffold.147,148 The
scaffolds need to allow for the appropriate transport of gases, nutrients, proteins, and
waste into and out of the cell.132,149 Diffusion properties are determined by the interaction
of the cells, molecules, waste, etc. compared to the pore size in the hydrogel.149 Knowing
the pore size in the hydrogel scaffold becomes important when determining what
substances can be transported. The hydrogel scaffold also needs to be able to promote
desirable cellular functions for its specific applications while not causing an
inflammatory response.142 Thus, the biological properties of the hydrogel play a key role
in success. Different polymers used to engineer hydrogel scaffolds have different
biological properties, all with their own strengths and weaknesses.132
The unique and tailorable features of hydrogels make them an attractive candidate
to minimize or eliminate the need for tissue and organ donors. These promising hydrogel
scaffolds can provide molecularly tailored biofunctions, adjustable mechanical properties,
and an environment that closely resembles the extracellular matrix to stimulate cell
growth and tissue formation.125 Hydrogel scaffolds in tissue engineering show promise in
creating a renewable source of transplantable tissue with desirable tissue regeneration
properties.150

POLY (ETHYLENE GLYCOL) HYDROGEL ELASTICITY
INFLUENCES HUMAN MESENCHYMAL STEM CELL BEHAVIOR

3.1

Permission for Publication

This chapter has been reproduced from Regenerative Biomaterials with
permission from their publisher, Oxford Academic.
3.2

Introduction

Parallel advances in biologically mimicking (biomimetic) material constructs and
in stem cell technologies enable the restoration and direct replacement of diseased cells
and tissues. To achieve these outcomes clinically, fully functional cells and tissues must
be produced on a large scale.151 Despite advances in the design and synthesis of
biomaterial scaffolds, one of the biggest obstacles facing tissue engineering is a lack of
understanding regarding the influence of extracellular cues on cell proliferation and
differentiation. The extracellular matrix (ECM) is a highly defined and specialized
microenvironment, which is essential for tissue development and function. The ultimate
decision of a cell to differentiate, proliferate, migrate, apoptose, or perform other
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functions, is a coordinated response to the physical and chemical interactions with these
ECM effectors.55
Matrix elasticity is one mechanical property of the ECM that differs between
tissues and can be manipulated in synthesized scaffolds to enhance tissue engineering
success and applications.152 Several studies have demonstrated that matrix elasticity can
influence stem cell behavior and differentiation toward certain lineages, indicating the
power of physical environment on cell state.75,153–158 Notably, Engler et al. initially
demonstrated that lineage specification in stem cells can be directed by altering the
elastic modulus of polyacrylamide (PA) gels, showing that elasticities of 0.1-1, 8-17, and
25-40 kPa influence mesenchymal stem cell (MSC) differentiation toward neurogenic,
myogenic, and osteogenic lineages, respectively.75 Later, Wen et al. systematically
modulated the porosity, ligand density, and stiffness of PA hydrogels demonstrating that
varying substrate porosity did not significantly change the osteogenic and adipogenic
differentiation of human adipose-derived stromal cells and marrow-derived mesenchymal
stromal cells. These findings imply that the stiffness of planar matrices regulates stem
cell differentiation independently of protein tethering and porosity.159 However, the
influence of the many dynamic extracellular cues of scaffolds on stem cell proliferation
and differentiation remains unclear. Understanding these interactions are paramount for
the field of tissue engineering and regenerative medicine.
The importance of elasticity in influencing and directing cell behavior generates a
need for tailorable biomaterial scaffolds. Hydrogel based biomaterials have rapidly
become an attractive medium because their innate network closely resembles the
structure of the extracellular matrix, their elasticity can be tailored, they allow for rapid
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diffusion of hydrophilic nutrients, and they have a low content of dry mass, which
reduces irritation and degradation.160 These features allow the hydrogels to provide an
environment that is like that of the in vivo environment, as well as provide additional
control of the physical and mechanical properties affecting cellular proliferation and
differentiation. To be effective, the hydrogel scaffold must be capable of promoting
desirable cellular functions for its specific applications without causing an inflammatory
response. Different polymers used to engineer hydrogel scaffolds have different
biological properties, all with their own strengths and weaknesses. For example,
polyethylene glycol (PEG) polymers are biocompatible and bio-inert in nature. While
PEG has been studied for multiple applications the usefulness of PEG polymers for the
formation of tailorable biomimetic scaffolds in tissue engineering and regenerative
medicine has not been fully investigated.161–163 However, PEG acrylates are popular
polymers utilized as hydrogel biomaterials for tissue engineering applications.164
Previously, we demonstrated the generation of biomaterial scaffolds of varying elasticity
by implementing tailorable PEG hydrogels. Results showed that our hydrogel platform
are compatible with multiple stem cell types, specifically mouse embryonic stem cells
(mESC), human adipose stem cells (hASCs), and human bone marrow-derived
mesenchymal stem cells (hMSCs).48 Here, we further characterize the interactions of our
hydrogel platform with hMSCs. Mesenchymal stem cells (MSCs) are adult, multipotent
stem cells harvested from bone marrow, adipose tissue, umbilical cords, and muscle
49,165–167

. MSCs are known for their ability to differentiate into cell types of the mesoderm

lineage, with their differentiation into adipogenic, osteogenic, and chondrogenic lineages
being well described.102,168 These cells have the potential to be patient specific and, with
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several regenerative and immunosuppressive properties, clinically relevant, having been
used in approximately 700 clinical trials. 169 MSCs are currently being investigated as
potential cell sources to regenerate bone tissue, cartilage, ligament tissue, muscle, and
adipose tissue.170–174
To analyze the interactions between bone marrow-derived hMSCs and a hydrogel
platform, we selected two hydrogel compositions: 10% wt. PEG dimetharcylate
(PEGDMA) Mw 1000 and 10% wt. PEGDMA Mw 20,000 and the 3% wt. PEGDMA
Mw 1000 and 17% wt. PEGDMA Mw 20,000, which yield elastic moduli in the ranges of
50-60 kPa and 8-10 kPa, respectively. These two hydrogel compositions were chosen
because they are at the upper and lower ends of the physiologically relevant elasticities.
For conciseness, the hydrogels with an elastic modulus of 50-60 kPa are referred to as
“stiff hydrogels” and the hydrogels with an elastic modulus of 8-10 kPa are referred to as
“soft hydrogels”. Expanding on our previous work, here we demonstrate the utilization of
our PEG-based hydrogel blends to study the effect of elasticity on the characteristics and
differentiation potential of bone marrow-derived MSCs.48 We show that the hydrogels of
different elasticities produce changes in hMSC morphology and proliferation, which
provides support that the platform has the potential to produce changes in hMSC
behavior and cell state. Furthermore, we find that the different elasticities can subtly
influence stem cell differentiation potential, primarily in cell types of stiffer elasticity.
Our findings enhance the fundamental understanding of stem-cell biomaterial interactions
and open the door for the continued exploration of PEG-based hydrogel scaffold in tissue
engineering and regenerative medicine.
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3.3

3.3.1

Materials and Methods

Materials
Poly(ethylene glycol) dimethacrylate (PEGDMA) MW 1000 and MW 20,000

were purchased from Polysciences and were used as received. The ultraviolet (UV)
photoinitiator, 2-hydroxy-1-[4-(hydroxyethoxy) phenyl]-2-methyl-1 propanone (I2959)
and fibronectin were purchased from Sigma Aldrich. Methacrylate acid (MAA) was
purchased from Fisher Scientific and was passed through a basic alumina column prior to
use to remove inhibitor. Heptane was purchased from Fisher Scientific. 1-Ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC), sulfo- N-hydroxysulfosuccinimide (sulfoNHS), 2-(N-morpholino) ethanesulfonic acid (MES) Buffer, and 1X Phosphate Buffer
Saline (PBS) were purchased from Thermo Fisher Scientific.
Human MSCs were provided by Dr. Bruce Bunnell from Tulane University.
Adipogenic differentiation media and osteogenic differentiation media were purchased
from LaCell. MEM α, L-Glutamine, Penicillin Streptomycin, ReadyProbes® Cell
Viability Imaging Kit (Blue/Red), Alexa Fluor 555 Phalloidin, and TRIzol reagent were
purchased from ThermoFisher Scientific. Fetal Bovine Serum (FBS) was purchased from
Atlanta Biologicals. Formalin was purchased from Azer Scientific. Triton X-100 was
purchased from Alfa Aesar. Methanol was purchased from VWR. BSA was purchased
from Amresco. qScript cDNA SuperMix was purchased from Quanta Biosciences.
Powerup SYBR green master mix was purchased from Applied Biosystems.
AlamarBlue® reagent, and 4',6-Diamidino-2-Phenylindole, Dihydrochloride (DAPI) was
purchased from ThermoFisher Scientific.
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3.3.2

Hydrogel Preparation
Hydrogel solutions for the “stiff” hydrogels (10% wt. PEGDMA Mw 1000 and

10% wt. PEGDMA Mw 20,000) and the “soft” hydrogels (3% wt. PEGDMA Mw 1000
and 17% wt. PEGDMA Mw 20,000) were prepared in deionized water (DH2O) as
previously reported7. 0.1% wt. UV photoinitiator, 2-hydroxyl-1-[4-(hydroxyl) phenyl]-2methyl-1 propanone (I2959), which is below concentrations previously determined to be
cyto-compatible175 and 2% wt. MAA was added to the hydrogel solution. Solution was
sonicated for 20 minutes and then pipetted in between two photomasks separated by
0.55mm stripes of teflon and UV polymerized at a wavelength of 365 nm and an intensity
of ~ 34 mW/cm2. Stiff and soft hydrogels were UV polymerized for 10 minutes and 20
minutes, respectively. The hydrogels were then rinsed for 10 days in DH2O (periodically
changed) to remove any un-reacted polymer or monomer. Prior to cell culture, hydrogels
were functionalized with fibronectin via EDC/Sulfo-NHS chemistry as previously
described.48
3.3.3

Characterization of Hydrogel Swelling
Hydrogel swelling studies were performed as previously reported.176,177 After UV

polymerization, hydrogel films were cut into ~19.5 mm discs and were weighed in air as
well as in heptane (a solvent the PEG hydrogels will not swell in) to obtain the volume of
the hydrogels immediately after UV-polymerization. The hydrogels were then rinsed for
10 days in DH2O (periodically changed) to remove any un-reacted polymer. Hydrogel
discs were then dried for 5 days under vacuum and subsequently weighed to obtain dry
(or polymer) mass. The dried hydrogels were then swollen for 48 hours in DH2O to
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reach swollen equilibrium. The polymer volume fraction in the swollen state, ν2,s and
relaxed state ν2,r was calculated from the measured hydrogel mass in air and in heptane:
𝑣2,𝑠 =

𝑊𝑎,𝑑 − 𝑊𝑛,𝑑
𝑊𝑎,𝑠 − 𝑊𝑛,𝑠

Eq. 3-1

𝑣2,𝑟 =

𝑊𝑎,𝑑 − 𝑊𝑛.𝑑
𝑊𝑎,𝑟 − 𝑊𝑛.𝑟

Eq. 3-2

where Wa.d is the hydrogel weight in dry state in air, Wn.d is the hydrogel weight in
dry state in heptane, Wa.s is the hydrogel weight in swollen state in air, Wn.s is the hydrogel
weight in swollen state in heptane, Wa.r is the hydrogel weight in the relaxed state in air,
and Wn.r is the hydrogel weight in the relaxed state in heptane. The equilibrium volume
swelling ratio (Q) was calculated by comparing the ratio of the equilibrium swollen
volume with the polymer volume at the dry state.175 Pore sizes were determined using the
equation:
1/2
−1/3 2𝐶𝑛 𝑀𝑐
( 𝑀 ) 𝑙
𝑟

𝜉 = 𝑣2,𝑠

Eq. 3-3

Where ξ is the pore size, 𝑣2,𝑠 is the polymer volume fraction in the swollen state,
𝐶𝑛 is Flory characteristic ratio, 𝑀𝑐 is the average molecular weight between crosslinks,
𝑀𝑟 is the molecular weight of the monomer, and Ɩ is the bond-length along the backbone
chain. The 𝑀𝑐 is found by using the Merrill and Peppas equation:
1
̅̅̅̅
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Eq. 3-4
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Where 𝑀𝑛 is the number average molecular weight of the uncrosslinked polymer,
v is the specific volume of the polymer, 𝑉1is the molar volume of the water, 𝑣2,𝑟 is the
polymer volume fraction in the relaxed state, and 𝜒₁ is the polymer-solvent interaction
parameter.
3.3.4

Maintenance of hMSCs
Human MSCs were cultured on 10 cm polystyrene tissue culture dishes in

maintenance medium containing MEM α, L-Glutamine, penicillin streptomycin and
16.5% FBS. The cells were incubated at 37°C with 5% CO2.
3.3.5

Osteogenic and Adipogenic Differentiation
Human MSCs were seeded on tissue culture plates and soft hydrogels at a density

of 2.0x103 cells/cm2 and grown until 80% confluence. Due to decreased proliferation of
hMSCs on stiff hydrogels, hMSCs were seeded on these specific gels at 4.0x103
cells/cm2 and attached at 80% confluence. The appropriate differentiation media
(adipogenic differentiation media or osteogenic differentiation media) was added to the
cells in all cases when cells demonstrated 80% confluence. Differentiation media was
changed every 72 hours until time point for analysis.
3.3.6

Cell Viability Assay
Cell viability was determined using the ReadyProbes® Cell Viability Imaging Kit

(Blue/Red) and imaged on the EVOS FL imaging system. Assay was done following
manufacturer's protocol.
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3.3.7

F-actin Staining
Alexa Fluor 555 Phalloidin was dissolved in methanol to create a stock solution

with a final concentration of 200 units/mL. The final staining solution contained a 1:40
ratio of Methanolic stock to PBS, with 1% BSA. Cells were protected from direct light
and incubated in staining solution for 15 minutes. DAPI was added to each well at a final
concentration of 1:2000 and incubated for an additional 5 minutes. Cells were washed
with PBS three times and imaged.
3.3.8

Cell Attachment Studies
Human MSCs were seeded at a density of 2.0x103 cells/cm2 per sample and

allowed to attach for 18 hours. Cells were fixed with formalin and permeabilized with
0.2% Triton X-100. Cells were incubated in a 1:1000 solution of DAPI and blocking
buffer (0.2% Triton X-100 and 1% wt. BSA in 1X PBS) for 10 minutes. Cells were
washed with PBS three times, and 500µL of PBS was added to each well for imaging.
The fluorescence was visualized and imaged using the EVOS FL cell imaging system.
Three images were taken per well (top, middle, and bottom). ImageJ was used to count
the nuclei per image. The average of the three images was taken for each sample.
3.3.9

Quantitative RT-PCR
RNA was collected and extracted from each cell type using TRIzol reagent

following the manufacturer’s protocol. The RNA was quantified using a Take3 plate on a
BioTek plate reader. RNA concentrations used for cDNA synthesis are shown in Table
S1. Due to low RNA concentrations in undifferentiated MSCs, each sample for that
experiment was a pool of three wells from a 24-well plate. cDNA was synthesized
following the protocol provided by Quanta Biosciences for their cDNA SuperMix kit.
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The expression levels for each marker were quantified by qRT-PCR according to the
manufacturer’s protocol on an Applied Biosystems StepOne Plus instrument. Each
reaction was performed in triplicate for every sample and the relative expression levels
were determined by normalizing to gapdh.
3.3.10

AlamarBlue™ Assay
4.0x103 hMSCs were seeded on all three surface types and grown under standard

conditions for 72 hours. At 72 hours, alamarBlue® reagent was added to culture media at
10% of the sample volume. Blanks for each sample were prepared by adding equivalent
amounts of culture media and alamarBlue® reagent to wells containing corresponding
elasticity conditions, without hMSCs. Samples were incubated at 37ºC and protected
from direct light. Readings were taken at 1, 2, 3, 4, and 24 hours post alamarBlue®
reagent introduction. Fluorescence was measured at excitation 560/emission 590 using a
BioTek plate reader.
3.3.11

Statistical Analysis
All data are expressed as mean with error bars representing standard error (SE)

for all quantitative comparison experiments. Statistical analysis was carried out via oneway analysis of variance (ANOVA) tests, using SPSS software v 24. p < 0.05 was
considered statistically significant. Significant results were further analyzed via Tukey
HSD post-hoc test and a p-value < 0.05 was considered significant.
3.4
3.4.1

Results

Characterization of Hydrogel Swelling
Swelling behavior of the synthesized stiff (50-60 kPa) and soft (8-10 kPa)

hydrogels was measured to determine the average molecular weight between crosslinks,
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network pore size, and swelling ratio using standard swelling protocols reported
previously. The results are summarized in Table 3-1.
While the total percent polymer was held constant at 20% wt. the amount of Mw
1000 and Mw 20000 was varied to create more elastic hydrogels. As expected, the
molecular weight between crosslinks and the pore sizes was larger in the soft hydrogels
compared to the stiff hydrogels. The equilibrium swelling ratio (Q) of the soft hydrogel
formulations is twice that of the stiff hydrogels.

Table 3-1. Pore sizes of Stiff and Soft Hydrogels. Reprinted with permission from Oxford
Academic.
Elastic
V2,r
Modulus
(kPa)
Stiff
10%
50-60
0.18 ±
Hydrogels MwPEGDMA
5.11E20,000 / 10%
3
PEGDMA
Mw 1000
Soft
17%
8-10
0.19 ±
Hydrogels MwPEGDMA
7.71E20,000 / 3%
3
PEGDMA
Mw 1000
Patel et
20% Mw
388-390 0..24 ±
al.
PEGDMA
0.01
reference 1000
hydrogels
Composition

3.4.2

V2,s

Mc
(g/mol)

Q

ζ (Å)

0.094
±
2.31E3

1379.11 10.58 52.58
± 50.98 ± 0.26 ± 1.34

0.043
±
1.72E3

4691.12 23.45 127.82
±
± 0.91 ± 3.21
130.88

0.18 ±
1.30E3

256.13
± 8.32

5.56 ± 17.77
0.04
± 0.32

hMSC Attachment to Hydrogels
Bone marrow-derived hMSCs were seeded on the hydrogel scaffolds and after 72

hours a viability assay was performed to determine if the cells survived on each of the
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three elasticity conditions: tissue culture plates, soft hydrogels, and stiff hydrogels. Based
on propidium iodide staining (dead cells stained red), we observe few, if any, dead cells
on each of the elasticity conditions (Figure 3-1A). The difference in image brightness
observed from the stiff hydrogels is attributed to the decreased porosity, which further
obstructs visualization. The difference in brightness does not alter the number of
live/dead cells.
Cell morphology can be an indicator of cellular state, and changes to this
morphology could indicate changes in cell behavior. Therefore, F-actin filaments of cells
cultured on all three elasticity conditions were stained and visualized (Figure 3-1B).
Cells on the soft hydrogels maintained similar morphology to the tissue culture plate
controls. In contrast, hMSCs cultured on stiff hydrogels displayed a more elongated
morphology than mesenchymal stem cells cultured on tissue culture plates or soft
hydrogels.
ImageJ software was used to analyze the images from the F-actin staining
experiment to further confirm differences in cell number observed between the three
elasticity conditions. The number of DAPI stained nuclei in each image was counted and
the average of three samples per condition type was determined. Importantly, all hMSCs
shown in Figure 1B were seeded at the same density, cultured for 72 hours, and analyzed
at the same exposure. As mentioned above, the differences in image brightness observed
from the stiff hydrogels is attributed to the decreased porosity, which further obstructs
visualization when viewed through an inverted microscope. The difference in brightness
does not affect the cell count, as ImageJ was still able to differentiate individual nuclei
(Figure 3-1C). The cell count analysis revealed a significant difference in the number of
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nuclei on stiff hydrogels compared to the tissue culture plate control, but no significant
difference between the soft gels and that same control was observed (Figure 3-1D).

Figure 3-1: hMSCs attach to and survive on the different hydrogel compositions. A)
Viability assay of hMSCs cultured on tissue culture plates, stiff hydrogels, and soft
hydrogels for 72 hours. Live cell nuclei are shown in blue, while dead cell nuclei are
shown in red. B) Morphology of hMSCs cultured on the three surfaces for 72 hours.
The cell nuclei are shown in blue, while the F-Actin filaments are shown in red. C)
Visual depiction of ImageJ analysis highlighting nuclei for count. D) Cell count
results from ImageJ quantification of cells seeded for 72 hours. *= Tukey HSD
resulting P < 0.05. n=3. Scalebars: 400µm. Reprinted with permission from Oxford
Academic.

46
To determine if this difference in cell number was the result of a difference in
initial cell attachment, the number of adherent cells was counted 18 hours after seeding.
ImageJ analysis of DAPI stained cells on each surface revealed a significant increase in
the number of cells attached to both soft and stiff hydrogels compared to the tissue
culture plate control. This indicates that attachment is not responsible for the decrease in
the number of cells present on the hydrogels after 72 hours. Alternatively, differences in
rate of proliferation could explain a difference in cell number. An alamarBlue assay was
utilized as an indicator of cellular proliferation, and the results show significantly less
metabolic activity in cells cultured on stiff hydrogels compared to soft hydrogels and
tissue culture plates at 3, 4, and 24 hours. At 24 hours, metabolic activity was
significantly higher in cells cultured on tissue culture plates compared to both stiff and
soft hydrogels. Given that proliferation is slower on the stiff hydrogels, the expression of
the multipotency marker sox2 was analyzed to see if there were significant changes in
multipotency. Cells were seeded at the same density on each surface and cultured for 72
hours before collecting RNA. Results of qRT-PCR of sox2 (Figure 3-2E) indicates that
there is no statistically significant difference in expression levels between each surface,
demonstrating that the elasticity conditions do not immediately influence the levels of
certain multipotency transcription factors.
3.4.3

Effect of Elasticity on hMSC Osteogenic Differentiation
To be useful in tissue engineering and regenerative medicine, biomaterial

scaffolds must be able to support and potentially direct stem cell differentiation toward
desired lineages. Elasticity can play a role in directing stem cell state, thus the effects of
the hydrogel elasticities on hMSC differentiation towards an osteogenic lineage were

47
investigated. Osteogenic differentiation was chemically induced in hMSCs seeded on all
three elasticity conditions, and morphology was analyzed using phase contrast
microscopy (Figure 3A). Due to the limited visibility in phase contrast images with
hydrogels, phalloidin staining was also used to visualize F-actin filaments (Figure 3B).
There was noticeable differentiation and calcium deposition on all three elasticity
conditions. qRT-PCR of osteogenic markers runx2 and alp (Figure 3C) was performed
on samples collected at Day 7 of differentiation.
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Figure 3-2: hMSCs attach more readily to hydrogels, but display decreased
proliferation, despite equal expression of sox2. A) Example images of DAPI stain
hMSCs 18 hours post-seeding on the different surfaces. B) Schematic representation
of imaging method used for attachment studies. Three images were taken (as shown in
panel A) of each sample, with three samples per surface. C) Results of ImageJ
quantification of nuclei per image. D) Results of AlamarBlue analysis of hMSCs
cultured on each surface. AlamarBlue was added after cells were cultured for 72
hours, and timepoints shown in graph represent hours after AlamarBlue introduction.
E) Quantitative Reverse-Transcriptase PCR analysis of sox2 expression in hMSCs
cultured on surfaces for 72 hours. *= Tukey HSD resulting P < 0.05. **= Tukey HSD
resulting P < 0.01. n=3 for C, D, and E. Scalebars: 1000µm. Reprinted with
permission from Oxford Academic.
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Analysis indicated no significant differences in the early osteogenic
differentiation marker runx2 expression in hMSCs cultured on each surface. However,
there were significant differences in alp expression, an early marker of osteogenesis,
between soft hydrogels and stiff hydrogels (P<0.05), between soft hydrogels and tissue
culture plates (P<0.05), and between stiff hydrogels and tissue culture plates (P<0.01).

Figure 3-3: hMSCs retain the ability to differentiate toward osteogenic lineages on
all surfaces. A) Phase contrast images of hMSCs at Day 7 of osteogenic
differentiation. B) Morphology of hMSCs at Day 7 of osteogenic differentiation,
corresponding to the phase contrast images in Panel A. The cell nuclei are shown in
blue, while the F-Actin filaments are shown in orange. C) Quantitative ReverseTranscriptase PCR analysis of the osteogenic differentiation markers runx2 and alp in
hMSCs at Day 7 of osteogenic differentiation. *= Tukey HSD resulting P < 0.05. **=
Tukey HSD resulting P < 0.01. n=3 for C, D, and E. Scalebars: 200µm. Reprinted
with permission from Oxford Academic.
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3.4.4

Effect of Elasticity on hMSC Adipogenic Differentiation
Since hMSCs also have the potential to be used for adipogenic tissue

regeneration, we further assessed adipogenesis of these cells on each of the selected
surfaces. Adipogenic differentiation was chemically induced in cells seeded on all three
elasticity conditions, and morphology was analyzed using phase contrast microscopy
(Figure 3-4A). As in the previous set of experiments, phalloidin staining was used to
visualize F-actin filaments and provide higher resolution images of cell morphology
(Figure 3-4B).
Noticeable differentiation had taken place on each surface, with round globules,
some of which are indicated by green arrows in Figures 4A and 4B, indicating vacuoles
and adipogenic differentiation. Phalloidin staining of the cells shows that in areas where
lipid vacuoles formed there is a decrease in F-actin filaments. This trend is seen on tissue
culture plates, soft hydrogels, and stiff hydrogels. qRT-PCR of early adipogenic markers
ppar-y and srebp1c was performed on samples collected at Day 7 of differentiation.
Analysis indicates no significant differences in expression of these early adipogenic
markers between each surface.
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Figure 3-4: hMSCs retain the ability to differentiate toward adipogenic lineages
on all surfaces. A) Phase contrast images of hMSCs at Day 7 of adipogenic
differentiation. B) Morphology of hMSCs at Day 7 of adipogenic
differentiaition, corresponding to the phase contrast images in Panel A. The cell
nuclei are shown in blue, while the F-Actin filaments are shown in orange. Cells
containing lipid vesicles demonstrated a rearrangement of F-Actin filaments,
indicated by green arrows. C) Quantitative Reverse-Transcriptase PCR analysis
of the adipogenic differentiation markers ppar-γ and srebp1-c in hMSCs at Day
7 of adipogenic differentiation. Results considered insignificant with P > 0.05.
n=3. Scalebars: 200µm. Reprinted with permission from Oxford Academic.
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3.5

Discussion

Previously, we demonstrated that PEGDMA hydrogels with elasticities within a
physiologically relevant range (8-60 kPa) can be generated by varying the molecular
weight of the polymer 48. Here, we characterized hydrogels at the upper and lower ends
of this range, specifically in terms of their swelling behavior and interactions with
hMSCs. The swelling behavior of the hydrogels was used to determine the molecular
weight between crosslinks (Mc), the pore sizes (ξ), and the equilibrium swelling ratio (Q).
All three, as predicted were lower in the stiff hydrogels as compared to soft hydrogels.
Variability in the swelling characteristics between the two samples was attributed to the
higher percentage of PEGDMA Mw 20,000 within the soft hydrogels (Table 3-1). Next,
we characterized hMSC interactions when cultured on the stiff and soft hydrogels. As the
largest pores are nanometers in size and hMSCs have an approximate diameter range of
17.9 μm to 30.4 μm, there is no penetration of hMSCs into the hydrogel network. Thus,
hMSCs are cultured two-dimensionally on the surface of these hydrogels.
When seeded on both soft and stiff hydrogels, hMSCs were shown to attach and
remain viable (Figure 3-1A), further confirming the potential of this platform for use in
cell culture and tissue generation. However, changes in morphology were observed in
cells cultured on the different elasticities. Human MSCs cultured on the soft hydrogels
maintained similar morphology to the tissue culture plate controls. In contrast, hMSCs
cultured on stiff hydrogels displayed a more elongated morphology as compared to
hMSCs cultured on tissue culture plates or soft hydrogels (Figure 3-1B). These
differences in morphology could indicate a change in cell behavior, such as spontaneous
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differentiation. Furthermore, there appeared to be consistently fewer hMSCs on the stiff
hydrogels after 72 hours of culture. ImageJ quantification of the hMSCs shown in Figure
1B revealed significantly fewer cells on the stiff hydrogels (Figure 3-1D). The decrease
in hMSCs could be the result of decreased attachment to the stiff hydrogels. However,
attachment analysis 18 hours after seeding actually revealed an increased number of
hMSCs attached to both hydrogel elasticities compared to tissue culture plate indicating
that the difference is a result of changing cell behavior after attachment (Figure 3-2A).
AlamarBlue assays demonstrated that proliferation is significantly decreased in
the cells cultured on either soft or stiff hydrogels. Human MSC proliferation on stiff
hydrogels was shown to be significantly decreased 3-hours after the introduction of
AlamarBlue. The differences in morphology and proliferation observed in hMSCs
cultured on stiff hydrogels could be an indication of spontaneous differentiation.
Quantitative RT-PCR analysis of the multipotency marker sox2 revealed no significant
differences in expression across the three elasticity conditions. However, further analysis
of multipotency markers and markers of possible differentiation lineages could reveal
that a subtle amount of spontaneous differentiation has taken place or longer time course
studies may demonstrate more significant changes in multipotency. For the scope of this
study, the differentiation potential of hMSCs on the three elasticity conditions was
analyzed through chemically induced differentiation toward osteogenic and adipogenic
lineages, rather than exploring the long-term effects of maintenance on each of these
surfaces.
On all three elasticity conditions, hMSCs cultured in osteogenic differentiation
media differentiated toward the osteogenic lineage, as evidenced by calcium deposition
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and expression of bone specific markers. There was no significant difference in runx2
expression, which is an essential transcription factor for osteoblastic differentiation
(Figure 3-3C). However, there was a significant decrease in alp expression in hMSCs
cultured on both hydrogel elasticities (Figure 3-3C). While lower levels of alp
expression could indicate decreased osteogenesis, given the observation of calcium
deposition and cell morphology, it is also possible that a decrease in alp expression is an
indication of more rapid maturation of the resulting cells.
hMSCs cultured in adipogenic differentiation media also retained the ability to
differentiate toward adipogenic lineages on all three elasticity conditions. hMSCs on all
three elasticity conditions began forming lipid vesicles characteristic of adipogenic
differentiation (Figure 3-4A&B). There was no significant difference in the expression
of two key transcription factors involved in adipogenesis, ppar-γ and srebp1-c.
Ultimately, no difference in hMSC differentiation toward adipogenic lineages was
observed.
In summary, the data from this study gives insight into the properties and stem
cell interactions of our previously established hydrogel platform, an inexpensive, highly
tailorable platform that can be adapted to any number of cell-material interaction studies
and applications. Changes in hMSC morphology and proliferation were observed in cells
cultured on hydrogels, primarily those cultured on stiff hydrogels. These results
demonstrate that the elastic tailorability of this hydrogel platform can produce changes in
hMSC behavior and cell state, indicating a potential for these hydrogels to be used to
generate a controlled environment for cell culture and tissue regeneration applications.
Furthermore, based on the differentiation studies, the different hydrogel elasticities have
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subtle effects on stem cell differentiation. This effect is observed primarily in osteogenic
differentiation, which could indicate that cell lineages of higher elasticity are more
susceptible to elasticity changes. The results of this study further suggest that the
hydrogel platforms do affect stem cell behavior, opening the door to future investigations
of the platform’s potential for controlling stem cell fate. Better understanding of the
biomaterial scaffolds utilized in regeneration, such as the studies shown here, is essential
in optimizing their translational and clinical potential.

POLY (ETHYLENE GLYCOL) HYDROGEL SCAFFOLDS WITH
MULTISCALE POROSITY FOR CULTURE OF HUMAN ADIPOSEDERIVED STEM CELLS

4.1

Permission for Publication

This chapter has been reproduced from the Journal of Biomaterial Science,
Polymer Edition with permission from their publisher, Taylor and Francis.
4.2

Introduction

Parallel advances in biomimetic materials and stem cell technologies have the
potential to enable the restoration and direct replacement of diseased cells and
tissues.125,178,179 Hydrogels are attractive material platforms for biomanufacturing because
of their high biocompatibility,120,180,181 hydrophilicity,182,183 tissue-like architecture,150,184
and innate biomimetic properties.160 Hydrogel materials have become an important tool
in developing better tissue engineering scaffolds because of their ability to provide
structural support and high tissue density, while still closely resembling the in vivo
environment.125,132,185
A significant portion of stem cell research has involved the use of immortalized or
primary murine cell models for metabolic, pharmaceutical, and regenerative medical
56
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studies. While murine and other rodent models are invaluable, they fail to accurately
mimic human physiology and pathology at the cellular and molecular levels. Due to interspecies biological variability these stem cell sources will ultimately fail to achieve
clinical translational milestones. Human adipose-derived stem cells (hASCs) are a
promising, reliable cell source because they can be directly harvested from the patient’s
own adipose tissue making them patient-specific and clinically relevant. Human ASCs
are an abundant source of adult multipotent stem cells.41 This cell source can be easily
and readily harvested from patients through minimally invasive lipoaspiration and are
present in larger quantities when compared to bone marrow-derived mesenchymal stem
cells (MSCs).49,186 Like mesenchymal stem cells, adipose-derived stem cells are easily
maintained in culture and have the potential to be directed towards osteogenic,
chondrogenic, adipogenic, and myogenic lineages making them an ideal cell source for
autologous tissue scaffolds.49,187
Cells are highly sensitive to their surroundings. The defined and specialized cell
microenvironment, which is essential for tissue development and function, is the
extracellular matrix (ECM).53,54 The ECM can effect cell behavior by directly regulating
cell functions through receptor-mediated signaling, and this network can control the
mobilization of growth factors or differentiation factors.53 This means that the ultimate
decision for a stem cell to differentiate, proliferate, migrate, apoptose, or perform other
functions, is a coordinated response to the molecular interactions with these ECM
effectors.55
For an engineered biomaterial to be a successful tissue construct and support
tissue growth and/or repair, it must support the formation of tissue-relevant mimics, as
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well as promote cell attachment, cell migration, foster transport of nutrients and waste,
and form new ECM.57 Since the ECM is critical in cell proliferation and differentiation,
tissue engineering approaches have widely explored exogenous three-dimensional ECM’s
to engineer new tissues from isolated cells.58 Synthetic ECMs should facilitate the
localization and delivery of cells to specific sites in the body, maintain a 3D space for the
formation of new tissues, and guide the development of new tissues with appropriate
functions.53,58,59 Synthetic ECMs need a large surface-to-volume ratio to allow for a high
density of cells. Since the ECM varies in different tissues and at different stages of
development, choosing the appropriate mechanical and degradative properties are
important.54 Therefore, the chemical and physical properties of the biomaterial used in
tissue engineering plays an important role as it can serve as a substrate for attachment, be
used as a cell delivery vehicle, and activate specific cellular functions in localized
regions.60
Hydrogels are three-dimensional crosslinked polymer networks widely studied for
various biomedical applications including targeted drug delivery,183 wound healing
bioadhesives,188 artificial skin,189 articular cartilage,190 biomanufacturing,191 and tissue
engineering.125 A variety of natural and synthetic polymers have been used to synthesize
hydrogels.192 Of these, poly(ethylene glycol) (PEG) is FDA approved and widely used for
commercial medical applications.193 PEG hydrogels have been a popular choice of
synthetic biomaterial for regenerative medicine applications for decades.194 The innate
PEG properties, such as hydrophilicity, biocompatibility, and non-ionic nature194 allows
for its use in medicine.195 Most notable is the non-fouling, stealth properties of PEG
which prevents proteins and cells in the body from interacting with the polymer,
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eliminating immune reactions in vivo.188,194 The non-degradability of pure PEG hydrogels
creates a stable platform for examining material properties and cell-material interactions
in vitro.43,48 Photo-crosslinkable PEG derivatives such as poly(ethylene glycol)
dimethacrylate (PEGDMA) have been utilized for the generation of a vast number of
applications including coatings,196 adhesives,197 shape memory development,198,199 and
3D bioprinting.200,201 Dimethacrylate groups on PEGDMA allow for branched covalent
crosslinking; this increases hydrogel network integrity202 and surface functionalization
potential providing application specific tailorability.43,48
The pore size of the hydrogel network is dependent on the starting polymer
molecular weight, crosslinking density, and hydrophobic interactions incorporated during
the synthesis process.203 Altering the molecular weight or cross-linking density influences
the bulk properties of the hydrogel network such as swelling, matrix elasticity, and
cytotoxicity.204 Previously, our group has reported that varying polymer percentage and
PEG molecular weight will alter the mechanical properties of PEGDMA hydrogels.48
This is advantageous for producing biomimetic scaffolds for cell seeding which mimics
the elasticity of different natural tissues. The size of this innate porous network
determines the rate of fluid exchange as well as the size of molecules that can diffuse into
and out of the hydrogel.120,205 Previously, PEGDMA hydrogels synthesized in our lab
using UV polymerization demonstrated a sub-nano to nanoporous (~1-13 nm) network
post-synthesis.43 This nanostructure is suitable for the exchange of small molecules but is
not optimal for the migration of cells which like hASCs in our experience had an
approximate hydrodynamic radius of 15-16 microns will require pores on the micron
scale.206 The limitation of such scaffolds is that cells are cultured in a monolayer on the

60
surface of the hydrogel which only allows for 2D studies or cultures that require the cells
to be encapsulated within the hydrogel network during the crosslinking process; which
ultimately leads to potential exposure to free-radicals and/or ultra-violet (UV)
exposure.207–211 This exposure could potentially lead to irreversible alteration of the cells
causing double-stranded DNA breaks affecting cell viability, proliferation, or gene
expression. Such changes in cell behavior limits our ability to assess cell function in
relation to material properties independent of chemical changes occurring during the
synthesis process. To be able to investigate cell-material interactions in a 3D fashion,
microporous scaffolds are a better option as they allow cells to integrate within the
hydrogel network and provide more accurate examination of morphology and gene
expression.212
Scaffolds that have porous networks are attractive for tissue engineering
applications as they increase the surface area in which cells can attach and act as a
temporary extracellular matrix for cells.213,214 Kim et al. reports that porous
polycaprolactone scaffolds created by a centrifugation method enhance hASC
differentiation by altering the pore size of the material.206 This group reports that pore
sizes of approximately ~300-320 µm enhance osteogenesis and ~90-105 µm enhances
myogenesis of hASCs.206 This groups suggests that the varying ranges in pore sizes
reported for enhancing differentiation of hASCs can be contributed to pore architecture
formed during synthesis, varying materials, or the limited pore size ranges of scaffolds.206
Here we describe the synthesis of PEGDMA hydrogel scaffolds with multiscale
porosity through mild post-processing, freeze-dry lyophilization. Freeze-dry
lyophilization is a common drying method used to preserve material quality, architecture,
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and physical and chemical properties. It is widely used in food preservation, stabilization
of nutraceuticals215 and solid protein pharmaceuticals to increase shelf life,216–218 creation
of porous materials for ion transport,219 and tissue engineering.220 Freeze-dry
lyophilization has been explored for the generation of porous scaffolds using polymers
such as chitosan, gelatin, alginate, hydroxyapatite/poly(hydroxybutyrate-co-valerate)
(PHBV), silk fibroin, and hydroxyapatite-collagen blends.221–227 These porous scaffolds
of varying materials have been used to study the architecture created during freeze-dry
lyophilization, the changes in material properties, and cell migration. There is some
evidence to support the alterations of polymer material properties after freeze-dry
lyophilization as seen in porous chitosan scaffolds.182,228,229 Porous chitosan scaffolds of 1
- 250 µm pore sizes were obtained by varying the freezing conditions in the
lyophilization step.
Despite the independent use of PEG based hydrogel scaffolds and use of freezedry lyophilization for a variety of applications, to the authors knowledge, the specific
effect of freeze-dry lyophilization on PEG hydrogels has not been characterized.
Materials that contain PEG in some capacity have been characterized by changes in
swelling behavior, mechanical properties, and appearance using scanning electron
microscopy (SEM).230–232 While SEM provides information on hydrogel structure and
morphology, these images are often obtained in a dry state after coating with a
conductive material. Hydrogels synthesized for tissue engineering applications are
utilized in a hydrated state, therefore it is vital to understand the innate hydrogel network
in a swollen state to get a true understanding of the influence material properties have on
stem cell fate. The inability to quantify hydrogels in their native swollen state has
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hindered fully characterizing the effect of lyophilization on network pore size and
structure of PEG based hydrogel biomaterials. In addition, to our knowledge PEG
hydrogels have not been characterized using environmental scanning electron microscopy
(ESEM).
Our group has demonstrated that varying the molecular weight of the polymer
incorporated into the hydrogel network alters the bulk properties such as elasticity,
swelling profile, and pore size creating hydrogel scaffolds to fit a variety of tissue
engineering applications.43,48 Here, co-blends (weight by weight, % wt.) of PEGDMA
hydrogels molecular weight (MW) 20 kDa and 1 kDa; 0:20, 10:10, 15:5, and 17:3 were
synthesized (Figure 4-1) in two thicknesses, 1 mm (thin) and 7 mm (thick). To determine
how polymer MW, thickness, and drying method (air dried versus lyophilized), effect
hydrogel properties (network pore size and formation of micropores) ESEM images were
acquired along with traditional hydrogel swelling profiles to observe changes in pore
morphology and swelling properties respectively. Using the synthesized lyophilized and
non-lyophilized hydrogels, proliferation and morphology of hASCs on the scaffolds were
evaluated using fluorescence imaging to evaluate cell-material compatibility.
4.3

4.3.1

Materials and Methods

Materials
Poly (ethylene glycol) dimethacrylate (PEGDMA) molecular weight (MW) 1 kDa

and MW 20 kDa were purchased from Polysciences, PA, USA. The ultraviolet (UV)
photoinitiator, 2-hydroxy-1-[4-(hydroxyethoxy) phenyl]-2-methyl-1 propanone (I2959),
phosphate buffered saline (PBS) tablets were purchased from Sigma Aldrich, MO, USA.
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Methacrylic acid (MAA) and heptane were purchased from Fisher Scientific, MA, USA.
MAA was passed through a basic alumina column to remove inhibitor prior to use. 1Ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC), sulfo- Nhydroxysulfosuccinimide (sulfo-NHS), 2-(N-morpholino) ethanesulfonic acid (MES)
buffer, and 1X PBS solution were purchased from ThermoFisher Scientific, MA, USA.
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Figure 4-1: Experimental Process: Flowchart showing the factors varied for the
synthesis of thin and thick hydrogels and step-wise post-synthesis treatments and
subsequent analysis of hydrogels. Reprinted with permission from Taylor & Francis.

Human adipose-derived stem cells (hASCs) were purchased from LaCell, LLC.
Minimum essential media (MEM) α, L-glutamine, penicillin streptomycin, alamarBlue™
reagent, Alexa Fluor 555 phalloidin, and diamidino-2-phenylindole, dihydrochloride
(DAPI) were purchased from ThermoFisher Scientific, MA, USA. Methanol was
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purchased from VWR. Bovine serum albumin (BSA) was purchased from Amresco. Fetal
bovine serum (FBS) was purchased from Atlanta Biologicals. Formalin was purchased
from Azer Scientific. Triton X-100 was purchased from Alfa Aesar. Unless otherwise
stated, all materials were used as received.
4.3.2

Hydrogel Synthesis
Hydrogel precursor solutions containing a total of 20% wt. polymer were

prepared with varying concentrations of MW 20 kDa and MW 1 kDa PEGDMA
solutions as summarized in Chapter 3. Solutions: 0:20 (without PEGDMA MW 20 kDa
and 20% (wt.) PEGDMA MW 1 kDa), 10:10 (10% wt. PEGDMA MW 20 kDa and 10%
wt. PEGDMA MW 1 kDa), 15:5 (15% by wt. PEGDMA MW 20 kDa and 5% by wt.
PEGDMA MW 1 kDa), and 17:3 (17% wt. PEGDMA MW 20 kDa and 3% wt.
PEGDMA MW 1 kDa) were prepared with 0.1% wt. UV photoinitiator, I2959, 2% by wt.
of PEGDMA MW 1 kDa of MAA and deionized water as previously reported by our
group 43,48. Precursor solution was sonicated for 20 minutes and then pipetted in between
two glass photomasks separated by a 1 mm Teflon spacer and UV polymerized at 365 nm
wavelengths at an intensity of ~37 mW/cm2. Hydrogels of 2 thicknesses (t), 1 and 7 mm,
were synthesized using Teflon spacers and poly (dimethyl siloxane) (PDMS) mold,
respectively, between glass photomasks. Hydrogels of 1 mm thickness were called “thin”
and 7 mm thickness were called “thick” hydrogels. The 0:20, 10:10, 15:5, and 17:3
hydrogel blends were UV polymerized for 5, 10, 15, and 20 minutes, respectively.
Hydrogel samples were rinsed for 48 h in deionized (DI) water and dried using 2
methods, air-dried (AD) for 4 days, and freeze-dry lyophilized using liquid nitrogen
(LYO) (Figure 4-1).
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For cell culture studies, hydrogels were surface modified as previously
described43,48 to promote cell attachment. MAA was added to the hydrogel precursor
solution to create carboxyl groups on the surface of the cured hydrogels. Using ESC
chemistry these carboxyl groups can be activated to bond with amine groups. Briefly,
hydrogels that had been stored in DI water, were incubated in 0.1 M MES buffer at pH
4.7 for 24 hours. EDC and Sulfo-NHS were added to the hydrogels at a 10-molar access
(with respect to MAA concentration) and incubated for 30 minutes. Hydrogels were then
incubated with a 0.2 µg concentration of Fibronectin for 4 hours. Hydrogels were then
rinsed with 70% ethanol for 30 minutes followed by PBS for 24 hours and then placed in
complete culture media for cell seeding.
4.3.3

Hydrogel Morphology
ESEM images were obtained post drying and 48 hours after rehydration with DI

water using the FEI Quanta 3D FEG FIB/SEM system in ESEM mode at 20 kV. Dry
state samples were imaged at 100 Pa using a secondary electron detector while the
hydrated state samples were imaged using a gaseous secondary electron detector with a
chamber pressure of 450 Pa. Hydrogel samples used in imaging were synthesized in the
same batch, however separate samples were used for the dry and hydrated images.
4.3.4

Hydrogel Parameter Characterization

Immediately after UV polymerization, hydrogel discs of 19.5 mm were punched out from
the thin hydrogel sheets and weighed in air and heptane (a solvent PEG hydrogels does
not swell in) to obtain the relaxed state volume fraction, ν2,r Eq. 3-1 as described
previously 43,175.

67
Hydrogel discs were then rinsed for 10 days in deionized (DI) water to remove
any unreacted polymer with daily water changes. After rinsing, the hydrogel discs were
dried in a vacuum oven at approximately 45°C for 5 days then weighed in air and heptane
to obtain their dry state mass. The dried discs were swollen in phosphate buffered saline
(PBS 1X) for 7 days to reach swollen equilibrium. Once at equilibrium the mass in air
and heptane was recorded to obtain the volume fraction in the swollen state, ν2,s Eq. 3-2.
Wa.d is the hydrogel weight in dry state in air, Wn.d is the hydrogel weight in dry
state in heptane, Wa.s is the hydrogel weight in swollen state in air, Wn.s is the hydrogel
weight in swollen state in heptane, Wa.r is the hydrogel weight in the relaxed state in air,
and Wn.r is the hydrogel weight in the relaxed state in heptane. The equilibrium volume
swelling ratio, Q, is the ratio of the equilibrium swollen volume with the polymer volume
in the dry state.
The average molecular weight between crosslinks (𝑀̄𝑐 ) was calculated using the
Peppas-Merrill equation Eq. 3-3. Where 𝑀̄𝑛 is the number average molecular weight of
the uncrosslinked polymer, v is the specific volume of the polymer, 𝑉1 (18.016) is the
molar volume of the water, and 𝜒1 is the polymer-solvent interaction parameter (0.426)
175

. For the hydrogel blends, the average weight percent combination of the two

̅𝑛 . Pore size (ξ) was
respective molecular weight polymers was computed to obtain 𝑀
determined using Eq. 3-4.
The Flory polymer characteristic ratio (Cn), molecular weight of the monomer
(𝑀𝑟 ), and bond length along backbone chain (l) for PEG was reported to be 4, 44, and
1.47 Å, respectively.175
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4.3.5

Equilibrium Hydrogel Swelling
Swelling percentage of hydrogels were studied in DI water at room temperature.

The dry mass of the hydrogels was obtained and used in computing the percent swelling
as a function of time over a period of 5 days. Swelling behavior of the hydrogels as a
function of time was calculated as a percentage using Eq. 3-5, where wf is the weight of
the hydrogel at each time point and wi is the initial dry weight of the hydrogel.
4.3.6

Rheology
Thin AD and LYO hydrogels were cut into 20 mm discs for rheology

measurements. The shear elastic modulus (G’) of each sample was measured using a
Bohlin CVOR rheometer with a 20 mm parallel plate in oscillation mode. Amplitude
sweeps at various oscillation frequencies, 0.1, 1, and 10 Hz, and a controlled strain range
of 0.001 – 1 was used to determine the linear viscoelastic region (LVR). The G’ was
determined from a frequency sweep between 0.1 – 10 Hz at the stress and strain values
obtained from the LVR for each sample. Gap height for each sample was obtained by
measuring the thickness using Vernier calipers.
4.3.7

Degradation in Culture Conditions
For degradation studies thin hydrogels of each polymer blend were synthesized

and dried as previously described in the synthesis section above and were treated in the
same manner they were prior to cell seeding. After hydrogels were dried, they were
placed into 0.1 M MES buffer for 24 hours. The next day the hydrogels were transferred
into PBS and left to swell for 24 hours. After 24 hours the hydrogels were placed in CCM
at 37 °C for 72 hours. These conditions were utilized to mimic the process of surface

69
modification the hydrogels require for cell seeding. Every 24 hours the mass of the
hydrogels was recorded, and the swelling percentage was calculated using Eq. 3-5.
4.3.8

Stem Cell Maintenance
Human ASCs were cultured on 10 cm and/or 6 cm polystyrene tissue culture

treated dishes. Cells were maintained in complete culture medium containing MEM α,
1% L-glutamine, 1 % penicillin streptomycin, and 16.5 % fetal bovine serum (FBS).
Stem cells were incubated at 37 °C at 5 % CO₂.43
4.3.9

AlamarBlue™ Assay
Human ASCs were seeded on tissue culture plates, air-dried 10:10 hydrogels (1

mm thickness), and lyophilized 10:10 hydrogels (1 mm thickness). 10:10 hydrogels were
selected for cell studies based off of previous data that demonstrated these air-dried
blends have an elastic modulus of 50-60 kPa which is in a physiologically relevant
range.43,48 Cells were seeded on all surfaces at 2.0x10³ cells/cm² and cultured in
complete culture medium for 48 hours. At 48 hours, alamarBlue™ reagent was added to
culture medium at 10 % of the sample volume. Blanks corresponding to tissue culture
plates, air-dried hydrogels and lyophilized hydrogels were prepared by adding equivalent
volumes of culture medium and alamarBlue™ reagent to corresponding wells without
hASCs. Samples were incubated at 37 °C and protected from light. Fluorescence was
measured using a BioTek Cytation 5 plate reader at excitation 560/emission 590.
Readings were taken at 1, 2, 3, and 4 hours following introduction of alamarBlue™
reagent.
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4.3.10

Phalloidin Staining
Human adipose-derived stem cells (hASCs) were cultured on tissue culture plates,

thin 10:10 air-dried hydrogels, and thin 10:10 lyophilized hydrogel scaffolds. 10:10
hydrogels were selected for cell studies based off of previous data that demonstrated
these air-dried blends have an elastic modulus of 50-60 kPa which is in a physiologically
relevant range of bone 43,48. Cells were seeded on all surfaces at 2.0x10³ cells/cm² and
cultured in complete culture medium for 72 hours. After 72 hours phalloidin and DAPI
stains were utilized to visualize cellular morphology of hASCs seeded on tissue culture
plates, 10:10 thin AD samples, and 10:10 thin LYO samples. Human ASCs were fixed in
10 % formalin and permeabilized using 0.2 % TritonTM X-100. AlexaFluor® 555
phalloidin was prepared with methanol according to manufacturer’s specifications. For
staining of hASCs, a dilution of 1:40 methanolic stock to PBS with 1 % BSA was used.
Staining was performed in an area protected from light and incubated for 15 minutes.
DAPI was added at a final dilution of 1:2000 and incubated for an additional 5 minutes.
Samples were then washed three times with PBS. Samples were imaged with 500 μL of
PBS in each well.
4.3.11

Statistical Analysis
Swelling data is presented as mean ± standard error of the mean. Two-way

ANOVA followed by Tukey’s multiple comparison test, 3 factor ANOVA and factor
interaction effect were determined using GraphPad Prism version 6.00 for Windows,
GraphPad Software, La Jolla California USA. Effects were considered significant if the p
value was less than 0.05. All data were collected in triplicate.
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AlamarBlue™ and ESEM pore size data was analyzed using a one-way ANOVA
followed by Tukey HSD post-hoc test from the online software available at astatsa.com.
The data is presented as mean ± standard error of the mean. Significance was determined
if the p value was less than 0.05 and each sample was measured in triplicate.
4.4

4.4.1

Results

Hydrogel Morphology
Environmental scanning electron microscopy (ESEM) was used to obtain cross-

sectional images of the hydrogels in the dry (Figure 4-2) and hydrated state (Figure 4-3).
Visual differences could be seen in morphology between air-dried (AD) and lyophilized
(LYO) samples. For images with visible micropores, ImageJ was used to measure pore
size (Figure 4). Specific values are available in Appendix Table E-1.
ESEM imaging in dry state: Samples imaged in the dry state (Figure 4-2)
exhibited induced microporous structures visible in 17:3, 15:5, and 10:10 blends of the
LYO samples. The 0:20 hydrogel swelling capability may have limited the water content
within the hydrogel to a point that microporous structures were not formed. It is also
possible that the pore size was within the network size or not visible with currently
available technology. Within the thin LYO samples that were imaged in the dry state, the
15:5 hydrogels had a larger average pore size of 27. 53 ± 57.88 microns in comparison to
the 17:3 which was 24.94 ± 11.44 microns but had less consistent pore diameter as
evident from the higher standard deviation (Appendix Table E-1). Pores were not
observed within any polymer blend for the AD hydrogel controls.
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Figure 4-2: Dry state ESEM images of thick (7 mm) and thin (1 mm) air-dried (AD)
and lyophilized (LYO) PEGDMA hydrogel blends (20 kDa : 1 kDa). Reprinted with
permission from Taylor & Francis.

ESEM imaging in hydrated state: Hydrogel samples that were imaged in the
rehydrated state using ESEM (Figure 4-3) demonstrated porous structures in all
lyophilized hydrogel samples regardless of thickness. When imaged in the hydrated state,
thickness appeared to affect pore size more than when the hydrogels were imaged in the
dry state.
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Figure 4-3: Hydrated state ESEM images of thick (7 mm) and thin (1 mm) air-dried
(AD) and lyophilized (LYO) PEGDMA hydrogel blends (20 kDa : 1 kDa). Reprinted
with permission from Taylor & Francis.
As seen in Figure 4-4, within the 17:3, 15:5, and 10:10 hydrogel blends, the
thick hydrogels demonstrated larger pore sizes than their respective thin hydrogels.
Hydrogel blends of 0:20 did not follow the same trends. This could be due to the
incorporation of more, higher molecular weight polymer, demonstrating that polymer
blend plays a crucial role in determining hydrogel properties.
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Figure 4-4: Average diameter of lyophilized samples as a function of polymer blend
and sample thickness, calculated from ESEM images using ImageJ software. Average
pore diameter of samples imaged in a rehydrated state. All samples are shown as the
average ± standard error. Samples not shown did not have visible pores within ESEM
images. There were no air-dried samples with measurable pore size diameters and
were excluded from the graph. Each sample had 15-20 images analyzed when
calculating pore diameter. Reprinted with permission from Taylor & Francis.
Thin LYO hydrogels appear to have a more uniform microporous structure when
visually compared with their thick LYO counterparts as seen in Figure 4-3. Similar to
ESEM images obtained in the dry state, there were no microporous structures visible in
any AD hydrogel formulation when imaged in the hydrated state. The structures seen in
Figure 4-3 for AD samples do not resemble true pores and appear to be voids that could
have been defects in the hydrogel or damage caused by cutting samples to obtain cross
sectional images. The smooth surface of the hydrogel surface indicates that overall this is
a uniform/flat, not a microporous network like those seen in the LYO samples.
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Unexpectedly, the 10:10 thick LYO hydrogels demonstrated the largest pore size
estimated through ESEM analysis.
4.4.2

Hydrogel Network Characterization
Bulk hydrogel parameters (Table 4-1), swollen volume fraction (𝜈2,𝑠 ),

̅𝑐 ), and the pore
equilibrium swelling ratio (Q), molecular weight between crosslinks (𝑀
size (ξ) were calculated as described above. The density (ρ) for each blend was also
calculated during equilibrium swelling studies. The total percent polymer remained
constant at 20% wt. for all polymer blends. The pore sizes described in Table 4-1
represent the theoretical network pore sizes for thin, air-dried samples as they are airdried for measurement purposes. Theoretical pore sizes were only calculated for thin
samples.

Table 4-1 Bulk hydrogel network properties of AD PEGDMA hydrogel blends, MW 20
kDa: 1 kDa, n=3. Reprinted with permission from Taylor & Francis.
PEGDMA
Hydrogel
Blends 20
kDa : 1
kDa
17:3
15:5
10:10
0:20

̅ 𝒄 (Da)
𝑴

Q

4691.12 ±
130.88
3321.29 ±
126.17
1379.11 ±
50.98
256.13 ±
8.32

𝝆 (g/cm3)

𝒗𝟐,𝒔

𝝃 (nm)

23.43 ± 0.91 1.00 ± 0.00

0.04 ± 0.00

12.28 ± 0.32

17.40 ± 0.57 1.02 ± 0.01

0.06 ± 0.02

9.59 ± 0.28

10.58 ± 0.26 1.02 ± 0.00

0.10 ± 0.02

5.11 ± 0.13

5.56 ± 0.04

0.18 ± 0.01

1.78 ± 0.03

1.17 ± 0.00
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The ratio of polymer percentage, PEGDMA MW 20 kDa to PEGDMA MW 1
kDa, was altered to determine how formulation will change bulk hydrogel properties. As
expected, as the percentage of higher MW polymer was increased the calculated network
pore size of the hydrogels increased as well. The molecular weight between crosslinks
̅𝑐 ) and swelling ratio (Q) also increase as the amount of PEGDMA MW 20 kDa is
(𝑀
increased in the hydrogel blends. In calculating the hydrogel parameters, the MW of each
hydrogel blend was based on a ratio of polymer MW. The trends observed through
equilibrium swelling studies confirms hydrogel pore sizes of air-dried PEGDMA
hydrogels increase as more of the higher MW polymer is incorporated. This allows for
controlled tunability of hydrogel properties by only altering the polymer composition
while the synthesis process remains constant.
4.4.3

Equilibrium Hydrogel Swelling as a Function of Post-Processing Drying

Method
The hydrogel swelling profile was obtained as a function of time in deionized
water over a period of 5 days. Three factors were evaluated: thickness, drying technique,
and increasing percentage of PEGDMA MW 20 kDa polymer in hydrogel polymer
composition. The factor combinations yielded 16 variations. Swelling profiles for all
combinations of thickness and drying method were similar for polymer blends 0:20 and
10:10 of PEGDMA MW 20 kDa : 1 kDa (Figure 4-5).
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Figure 4-5: Swelling profile of PEGDMA blended hydrogels with increasing ratio of
20 kDa : 1 kDa molecular weight PEGDMA polymer as a function of polymer blends,
n=3. Reprinted with permission from Taylor & Francis.
Thick LYO hydrogels achieved equilibrium in 3 days, thin LYO in 4 h, thin AD
in 6 h, while the thick AD samples swelled slowly and did not achieve equilibrium within
the 5 days studied (Figure 4-6).
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Figure 4-6: Swelling profile of PEGDMA blended hydrogels with increasing ratio of
20 kDa : 1 kDa molecular weight PEGDMA polymer as a function of polymer blends,
post-drying process, and sample thickness; n=3. Reprinted with permission from
Taylor & Francis.
No significant difference in swelling was observed after 8 h between the different
combinations of thickness and drying methods for 0:20 combination of PEGDMA MW
20 kDa : 1 kDa (Figure 4-5a). For both 15:5 and 17:3 blends of PEGDMA MW 20 kDa :
1 kDa, there was no significant difference in the swelling profiles between the thick and
thin lyophilized samples after 12 h (Figure 4-5c & d). No difference in swelling profile
was observed between the thick and thin air-dried sample of 15:5 PEGDMA MW 20 kDa
: 1 kDa after day 3.
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4.4.4

Rheology
The shear elastic modulus of thin AD and LYO hydrogel blends was evaluated

through rheology to have a better understanding of how drying method affects the
physical properties of the hydrogels. As expected, the shear elastic modulus increased as
the ratio of PEGDMA MW 1kDa increased regardless of drying method (Table 4-2).
Flash freezing and drying via lyophilization reduced the shear elastic modulus of all
hydrogel blends. This decrease in shear elastic modulus indicates that drying method not
only influences hydrogel morphology, but actually alters the elastic modulus even if the
polymer blend is held constant. The 0:20 hydrogel blends were too brittle to obtain
measurements from as they would crack during flash freezing and we could not obtain a
large enough sample to attempt rheological measurements.
4.4.5

Degradation in Culture Conditions
To confirm that these hydrogel blends would not degrade under cell culture

conditions, they were subjected to a process that mimics the surface modification
procedure required for cell seeding. Thin AD and LYO hydrogels of each polymer blend
were swollen in MES buffer followed by PBS then kept in CCM for 72 hours. The
hydrogels were only in CCM for 72 hours as that is the length of time cells were cultured
on the chosen blend. All blends, regardless of drying method, demonstrated an ability to
uptake fluid and keep a steady swelling percentage over time (Figure 4-7). The hydrogel
blends that contained more of the higher MW polymer had the most swelling capacity,
which was also seen in the equilibrium swelling studies performed in PBS. Degradation
was only evaluated for thin AD and LYO samples as they were the hydrogels used for
cell culture studies.
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Table 4-2 Shear elastic modulus of thin AD and LYO hydrogel blends shown as the
average ± standard error (kPa), n=3. Reprinted with permission from Taylor & Francis.
Drying Method

PEGDMA Hydrogel Blend
20 kDa : 1 kDa

Shear Elastic Modulus
(kPa) ± Standard Error

AD

17:3

12.04 ± 0.606

AD

15:5

19.47 ± 1.010

AD

10:10

36.19 ± 2.030

AD

0:20

LYO

17:3

3.22 ± 1.45

LYO

15:5

3.65 ± 0.003

LYO

10:10

16.50 ± 7.44

LYO

0:20

Too Brittle/Freeze Cracking

Too Brittle/Freeze Cracking

Figure 4-7: Degradation swelling performed utilizing a process that mimics surface
modification required to seed cells on these hydrogel scaffolds. Thin AD and LYO
samples were observed and their mass was recorded every 24 hours. The change in
mass is presented as a function of percent change in weight ± standard deviation, n=3.
Reprinted with permission from Taylor & Francis.
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4.4.6

Human ASC Attachment and Proliferation on Hydrogel Scaffolds
Human ASCs were cultured on thin 10:10 AD hydrogels and thin 10:10 LYO

hydrogels to observe if there were differences in cell attachment and viability between
the two drying techniques. 10:10 hydrogels were selected for cell studies based off of
previous data that demonstrated these air-dried blends have an elastic modulus and shear
modulus in a physiologically relevant range.43,48
An alamarBlue™ assay was conducted with readings taken at 1, 2 3 and 4 hours
post addition of alamarBlue™ (Figure 4-8). The alamarBlue™ assay was used to
demonstrate the proliferation rates on the hydrogel surfaces in comparison to the tissue
culture control. Analysis of hASCs on tissue culture plates, 10:10 thin AD hydrogels, and
10:10 thin LYO hydrogels suggest that there were no statistically significant differences
between the surfaces at any timepoint during the 4-hour analysis.

Figure 4-8: Fluorescent readings of hASCs cultured on tissue culture plates, 10:10
thin AD, and 10:10 thin LYO hydrogels 1, 2, 3, and 4 hours post addition of
alamarBlue™, n=3. Reprinted with permission from Taylor & Francis.
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Fluorescent images of hASCs cultured on the three surfaces 72 hours after
seeding were taken to evaluate cell morphology (Figure 4-9). Phalloidin stains the f-actin
filament of the cells highlighting the morphology of the cells on the three surfaces. A
DAPI stain was done to visualize the cell nuclei. Overlay images were created to show
both phalloidin and DAPI staining. Phase contrast images were also taken to help further
characterize the morphology of the cells. Qualitative results show that the hASCs are
attached to all three surfaces and remain viable. Morphologically, the cells remain in a
spindle fiber like morphology typical of hASCs. Our scaffolds show cell behavior
consistent with undifferentiated hASCs, including proliferation and normal cell
morphology.

Figure 4-9: Phalloidin staining of hASCs. Fluorescent images show the morphology
of hASCs cultured on the three surfaces 72 hours after seeding. Cell nuclei are shown
in blue and f-actin filaments are shown in orange. Scalebars: 200 mm. Reprinted with
permission from Taylor & Francis.
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4.5

Discussion

In this work microporous PEGDMA hydrogel scaffolds were synthesized through
freeze-dry lyophilization that could be used in the future to support systematic assessment
of surface topography on human adipose-derived stem cell fate. The differences in
hydrogel morphology between AD and LYO samples show that the drying method did
alter the architecture of the hydrogel for blends that had the 20 kDa PEGDMA through
the induction of micropores. When imaged in a dry state, thin and thick samples (Figure
4-2) of corresponding blends had similar morphologies, therefore it is not believed that
thickness has a noticeable effect on hydrogel morphology when samples are dried.
To our knowledge this is the first time that PEG hydrogels have been imaged
while in a hydrated state. This unique perspective allows for the visualization of the
hydrogel blends in their native state in which they would be used for tissue engineering
applications. Hydrated ESEM analysis indicated that polymer blend, thickness, and
drying method all play a crucial role in determining the pore size and morphology of the
hydrogel network and thereby influencing hydrogel behavior. The larger pore sizes seen
within 10:10 thick LYO hydrogels when imaged in the hydrated state could be due to
how the samples were prepared for imaging. As seen in Figure 4-3, some of the pore like
structures seen in the images resemble large voids resembling cracks in the network
rather than true pores. However, ESEM analysis of samples using ImageJ were all
blinded and before analysis characteristics of a pore were determined to be 3D voids that
penetrated multiple layers within the network for consistency. Theoretical network pore
size calculations using the Peppas-Merrill equation derived from equilibrium
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swelling studies presented nanoscale pore sizes for all AD control hydrogels
(Table 4-1). These values explain why pores on AD hydrogels were not visible
during ESEM imaging.
It was evident from the long-term swelling data collected as a function of postprocessing drying methods that the interaction of sample thickness and drying method
only affected the formulation with higher percentage of PEGDMA MW 20 kDa polymer
within the composition. Thicker samples contained more polymer mass, thus had greater
swelling prior to drying. The increase in higher molecular weight polymer led to an
increased hydrogel swelling capacity. Thus, the presence of increased water content in
PEGDMA blends with higher polymer percentage of MW 20 kDa. These results implied
that the relaxation of the polymer chain was the more prominent driving factor in
swelling rather than the drying method or sample thickness. The results also illuminate
novel findings in this field with respect to sample thickness and drying method, both of
which can be varied to alter the hydrogel architecture depending on the original hydrogel
chemical composition. This opens a new factor to consider when synthesizing application
specific hydrogels.
The rheology data provided insight into the physical properties of the hydrogel
blends and how polymer blend and drying method can alter these properties. As
expected, the shear elastic modulus decreased as the ratio of higher MW polymer
increased in AD as well as LYO samples. In addition, drying method also caused a
change in shear elastic modulus. All LYO samples that were investigated had a lower
shear elasticity than that of their AD counterparts. The 17:3 LYO hydrogels had the
lowest shear elastic modulus values while the 10:10 AD hydrogels had the highest shear
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elastic modulus values. Previously, the Young’s elastic modulus of the air dried then rehydrated 10:10, 15:5, and 17:3 hydrogels blends43,48 were within the physiologically
relevant elasticity ranges for bone (50-60 kPa), cartilage (25-30 kPa) and muscle (8-10
kPa) 75,233. In comparison the 10:10 AD hydrogel blend had a shear elastic modulus of
~36.19 kPa. Previous researchers have estimated the brain to have a shear modulus in this
range through modeling based off of cadaver experiments.234 Other groups such as
Nordez and Hug have utilized supersonic shear imaging to estimate the elastic modulus
of muscle. These researchers estimate that at rest muscle tissue has an elasticity of ~1011 kPa and ~21-23 kPa to ~42-45 kPa at 3% and 7% of electromyographic activity.235 As
it is difficult to measure the elasticity of tissue in the body and there are some
discrepancies in exact numbers, we chose to utilize the 10:10 hydrogel blend as it
demonstrated a shear elastic modulus similar to estimates of physiologically relevant
ranges. In addition, 10:10 thin LYO hydrogels had an average pore size closely
resembling that of hASC diameter suggesting it as a potential scaffold for embedded cell
culture and tissue engineering applications. Degradation analysis illustrates that all
hydrogels, regardless of blend or drying method, retain their structural integrity and their
swelling capabilities. Confirming that there is no hydrogel degradation indicates that we
can reliably reproduce results when these scaffolds are utilized, which is especially
important when they are used in conjunction with cells. The stability in cell culture
conditions will allow us to further study them for use in tissue engineering applications.
Biocompatibility of AD and LYO hydrogels was observed utilizing tissue culture
plates as a control since hASCs are commonly cultured on this surface. Over a 4-hour
period incubated in alamarBlue™ reagent, hASCs cultured on 10:10 thin AD samples,
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10:10 thin LYO samples, and tissue culture plates did not produce a statistically
significant difference in fluorescence. These results demonstrate that overall the
proliferation rates of hASCs are comparable between cells cultured on all three
conditions. Phalloidin staining of the F-actin filaments of hASCs cultured on each
scaffold qualitatively demonstrate that morphologically the cells hold a spindle-like
morphology indicative of undifferentiated hASCs. The results of the alamarBlue™ assay
and phalloidin staining demonstrates cell attachment and growth indicating cell-material
biocompatibility. Future studies will investigate how altering the properties influence cell
behavior on each hydrogel combination to create tuneable hydrogels to be utilized in
tissue engineering applications such as repair, replacement, wound healing, and drug
delivery.

EVALUATING THE INFLUENCE OF BIOCHEMICAL CUES ON
MYOGENIC DIFFERENTIATION OF HUMAN ADIPOSE-DERIVED
STEM CELLS

5.1

Introduction

It was first documented in the 18th century that mature skeletal muscle possessed
the ability to regenerate itself after chemical or physical injuries.236 However, there are
special cases where the injury to the skeletal muscle is too deleterious and the body
cannot repair or replace the damaged area. Volumetric muscle loss (VML) is
characterized by muscle injury that does not regenerate naturally and can occur due to
combat injuries, traumatic injuries such as car wrecks, surgical procedures such as tumor
removal, or abnormal muscle conditions such as muscular dystrophies.237 Numerous
studies have also shown that muscle degeneration, or atrophy, occurs as a consequence of
exposure to microgravity during spaceflight, something experience by astronauts who
spend significant periods of time on the International Space Station.238–242 The most
common treatments for VML including surgical procedures utilizing functional free
muscle transfers is severely limited by donor tissue availability, is invasive, and
contributes to an increase in scar tissue formation237 and advanced bracing.243,244 In 2015
it was reported that 4.5 million reconstructive surgeries characterized by volumetric
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tissue damage due to combat or traumatic injuries were performed.245 In 2016, a study
evaluating acellular biological scaffolds, composed of extracellular matrix of porcine
urinary bladder, for treating VML in a 13 patient clinical trial was published.246 From this
evaluation of 13 patients, 7 showed improvement, 3 had no change, and 3 had loss of
function. While the muscle bulking was present post treatment, biopsies did not show
evidence it was from muscle fiber formation.247 Recovery outcomes for those suffering
from VML are low and can likely lead to a lifetime of disability. It is estimated that the
disability cost per patient, including lost wages ranges between $340,000-$440,000.248
There is a growing need to find a solution to this debilitating and costly condition that
affects so many individuals. Producing 3D tissue scaffolds by combining biomaterials, a
cell source, and biochemical or physiochemical cues to direct skeletal muscle
differentiation has the potential to revolutionize the way in which VML is treated. Fully
developed myogenic tissue scaffolds will eliminate the need for donor tissue and
potentially restore function to the affected muscle. Despite this need, the challenge in
producing these dynamic scaffolds still lies in creating an environment that mimics the
natural extracellular matrix found in skeletal muscle tissue and allows the reliable
differentiation of stem cell populations towards a myogenic lineage.
Here we aim to understand how biochemical cues from media components and
EMC proteins influence myogenic differentiation of hASCs. Adipose-derived stem cells
are an abundant and reliable source of adult multipotent stem cells41 that are easily and
readily harvested from patients through minimally invasive lipoaspirates and are present
in larger quantities in contrast to bone marrow-derived mesenchymal stem cells
(MSCs).49,186 Like MSCs, adipose-derived stem cells can differentiate towards the
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osteogenic, chondrogenic, adipogenic, and myogenic lineages while being easy to
maintain in culture making them an ideal cell source for autologous tissue scaffolds.49,187
Adipose stem cells are also immunoprivileged and are genetically stable in long-term
culture.186 The ease with which these multipotent stem cells can be harvested and
maintained, along with their differentiation potential makes them an attractive, clinically
relevant cell source for tissue engineering applications. Finally, the fact that hASCs can
be used in an autologous manner makes them a top candidate in tissue engineering
applications for the treatment of tissue damage and degeneration.
While several groups have shown that hASCs have the potential to differentiate
towards a myogenic lineage,49–51 there is no universal myogenic differentiation media
that yields greater than 15% myogenic differentiation.52 Previously, Huri et al.249 reported
on a myogenic media B (Myo B) for directing myogenic differentiation in hASCs. In the
study, hASCs were seeded onto culture plates coated with type I collagen and exposed to
myogenic induction media (MIM) for 24 hours. Huri et al. looked at how providing a
biophysical stimulant would influence stem cell differentiation towards the myogenic
lineage in combination with the MIM. Groups were either “static” meaning exposed to
MIM but not experiencing uniaxial strain, or “dynamic” which were cells exposed to
MIM and uniaxial strain for one hour each day. Static cells did not begin to show
myotube formation until day 14 and even at day 21 there were significantly fewer
myotubes compared to the dynamic group. Cells cultured under dynamic conditions
began forming myotubes as early as day 7 and had 5-fold more myotubes than static
conditions by day 21. Immunohistochemistry of the late stage marker, myosin heavy
chain (MHC) was also observed between the two groups. Static cultures never expressed

90
MHC while dynamic samples began expressing MHC by day 21. This study shows that
while MIM alone can induce myotube formation, this media is insufficient in
demonstrating cells that are terminally differentiating towards a myogenic lineage as
observed by the absence of MHC expression.
Additionally, Zuk et al.49 previously reported on myogenic media C (Myo C) for
differentiation of lipoaspirate (PLA) cells towards a myogenic lineage. In this study, Zuk
et al. seeded processed lipoaspirate cells, also known as adipose-derived stem cells in
myogenic media (MM) for 1, 3 and 6 weeks. Differentiation towards a myogenic lineage
was determined utilizing reverse transcriptase polymerase chain reaction (RT-PCR) and
evaluating expression level of cells cultured in MM compared to those cultured in control
media. Cells cultured in MIM expressed six common skeletal muscle markers (myoD,
myf5, myf6, MHC, myogenin, and desmin). These were the only results on myogenesis
published in this article, however it was a continuation of Mizuno et al.’s publication on
myogenic differentiation51 where it was determined that only 15% of PLA cells could be
differentiated towards the myogenic lineage. While this media does induce hASCs
towards a myogenic lineage, the efficiency is low and leaves room for improvement.
Additional research is required to determine the optimal conditions for hASC
myogenic differentiation to find a more efficient and reliable protocol for successful
myogenic differentiation. Here we aim to optimize myogenic differentiation conditions
of hASCs to advance the likelihood of utilizing this abundant cell source for treating
muscle tissue damage and degeneration. To accomplish this, we evaluated the influence
of the two different media (Myo B and Myo C) individually and in combination with
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altered surface chemistry by coating tissue culture dishes with extracellular matrix
proteins (Figure 5-1).

Figure 5-1: Schematic illustrating the combination of media, extracellular matrix
protein, and time point to be evaluated. Each media (Myo B, Myo C, and CCM) will
be cultured on plates coated with collagen type I, fibronectin, laminin, and tissue
culture controls for 2, 4, and 6 weeks.
Since the biochemical stimulation of the media alone do not efficiently induce
myogenic differentiation, we paired collagen type I, fibronectin, and laminin with the
media to evaluate how altering the surface chemistry cells on which cells are cultured
influences myogenic differentiation potential. Collagen type I is one of the earliest
extracellular matrix proteins that is associated with the myogenesis process,236 and
collagen is also the most abundant structural protein found in skeletal muscle.250
Fibronectin is a critical cellular protein for cell-cell and cell-surface interactions, and
some studies have also shown the presence of fibronectin during proliferation of muscle
precursor cells.236 Finally, laminin is utilized as it is the most abundant glycoprotein in
the basal membrane of the ECM and has been shown to elongate muscle precursor
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cells.236 The important role of these three proteins in myogenesis extracellular matrix
formation is why they were chosen for inclusion in these studies.
To evaluate the role environmental chemistry has on hASCs, human ASC’s were
cultured in Myo B, Myo C, or complete culture media (CCM) in combination with either
collagen, fibronectin, or laminin for 6 weeks. Reverse-transcriptase polymerase chain
reaction (RT-PCR) of six common skeletal muscle markers was used to determine gene
expression and immunofluorescence was utilized to qualitatively evaluate myogenic
protein expression. Human skeletal myoblasts (HSkMs) were cultured and used as a
positive control. These cells were also used to optimize myogenic primers for RT-PCR
and MYOD immunofluorescence.
Moving forward the media plus protein combination that initially yielded the most
promising results were utilized. To further promote myogenesis 5-azacytidine, a DNA
methylation inhibitor,251 was added to Myo B and Myo C medias for 24 hours, after
which timethey were returned to normal Myo B and Myo C medias for 6 weeks. Under
these conditions, myogenesis was confirmed through RT-PCR of early, mid and late
muscle markers as well as immunofluorescence of myosin and MYOD. This combination
of biochemical stimulation lays groundwork for proceeding with creating a scaffold that
will effectively and efficiently mimic that of the natural ECM of skeletal muscle for
potential regenerative therapies.
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5.2

5.2.1

Materials and Methods

Materials
Human skeletal myoblasts were purchased from Invitrogen and cultured

according to manufacturer protocol. Human adipose-derived stem cells (hASCs) were
purchased from LaCell, LLC. Minimum essential media (MEM) α, low glucose
Dulbecco’s modified eagles medium (DMEM) L-glutamine, penicillin streptomycin,
Alexa Fluor 555 phalloidin, and diamidino-2-phenylindole, dihydrochloride (DAPI),
MYOD monoclonal antibody were purchased from ThermoFisher Scientific, MA, USA.
Methanol was purchased from VWR. Monoclonal myosin antibody, hydrocortisone, and
5-azacytidine were purchased from Sigma Aldrich, MO, USA. Bovine serum albumin
(BSA) was purchased from Amresco. Fetal bovine serum (FBS) was purchased from
Atlanta Biologicals. Formalin was purchased from Azer Scientific. Triton X-100 was
purchased from Alfa Aesar. Unless otherwise stated, all materials were used as received.
5.2.2

Human Skeletal Myoblast Culture
Human SkMs were thawed into media composed of low glucose DMEM and 2 %

horse serum. Cells were then centrifuged at 180 x g for 5 minutes. The media was
aspirated leaving a cell pellet. This was then resuspended in low glucose DMEM and 2 %
horse serum and seeded onto a 6 well polystyrene tissue culture plate. Cells were cultured
for 48 hours before collecting RNA or performing immunofluorescence.
5.2.3

Stem Cell Maintenance
Human Adipose-Derived Stem Cells (hASC) were cultured on 10 cm tissue

culture treated polystyrene dishes in complete culture medium (CCM) containing α MEM
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1x, 16.5% Fetal Bovine Serum (FBS), 1% L-glutamine 200mM (100x), and 1% Penicillin
Streptomycin. Cells were incubated at 37 °C at 5% CO2 and media was changed every
other day to ensure the cells were receiving proper nutrients.
5.2.4

Differentiation Medias
Human ASCs in 24 well plates were cultured in low glucose myogenic “B” media

(Myo B) and low glucose myogenic “C” media (Myo C) for 2, 4, and 6 weeks. Myo B
media contained low glucose Dulbecco’s Modified Eagle Media, 5 % Horse Serum, 1 %
Penicillin Streptomycin, and 1 % L-glutamine.249 Myo C media contained low glucose
Dulbecco’s Modified Eagle Media, 10% Fetal Bovine Serum, 5% horse serum, 50µM
hydrocortisone resuspended in ethanol, and 1% Penicillin Streptomycin.49 Cells were
passaged, seeded for experiments, and cultured in CCM for 24 hours. At this point 5azacytidine was added at a10 µM concentration in Myo C media (referred to as AZA
Myo C) and cells were cultured for 24 hours. Cells were then switched to Myo C for their
respective studies. Cells cultured in Myo B were switched to differentiation media 24
hours after passaging and exposure to CCM. Myogenic media was changed every 48
hours (Figure 5-2).
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Figure 5-2: Media components utilized and expectation of gene expression timeline
during myogenesis. Each media has different biomolecules to stimulate cell growth or
differentiation. The genes myf5 and myod are considered the master regulators of
myogenesis.
5.2.5

Surface Modification
To assess the influence of extracellular matrix proteins on cellular differentiation,

24 well non-treated tissue culture plates were coated with different extracellular matrix
proteins. These proteins included: 0.02 µg/µL concentration of collagen type 1, laminin,
or fibronectin diluted in PBS. Protein solutions were added at 250 µL per well and rocked
at 4 °C for 24 hours. Plates were then blocked with 1% BSA for 1 hour before cells were
passaged and seeded onto the surfaces.
5.2.6

Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
RT-PCR and was utilized to determine if common myogenic markers, desmin,

myf5, myf6, myogenin, mhc, and myod were expressed in hASCs after 2, 4, and 6 weeks
in culture with the various surface modifications and different medias. RNA was
collected from cells cultured in each combination of conditions and extracted from each
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experimental group using TRIzol reagent following the manufacturer’s protocol. The
RNA was quantified using a Take3 plate on a BioTek plate reader. cDNA was
synthesized following the protocol provided by Quanta Biosciences for their cDNA
SuperMix kit. Samples were denatured at 60 °C and underwent 35 cycles of PCR.
5.2.7

Immunofluorescence and Phalloidin Staining
Immunofluorescence staining of MYOD and Myosin antibody were used to

visualize transcription proteins used in muscle differentiation. Human ASCs were fixed
in 10% formalin and permeabilized using 0.2% Triton™ X-100. Immunofluorescence
was performed using MYOD specific antibody at a dilution of 1:200 and a myosin
specific antibody at a dilution of 1:150. Both were diluted in a 1 % BSA solution and fix
cells were incubated for 24 hours at 4 °C. AlexaFluor® 488 and AlexaFluor® 555
secondary antibodies were used at a 1:1000 dilution and incubated for 50 minutes at 4 °C.
After AlexaFluor® 555 phalloidin was prepared with methanol according to
manufacturer’s specifications. A dilution of 1:40 to PBS with 1% BSA was used for
phalloidin staining and incubated for 20 minutes at 4 °C. DAPI was added at a final
dilution of 1:2000 and incubated for 10 minutes at room temperature. Samples were then
washed three times with PBS and imaged with 500 µL of PBS in each well.
Immunofluorescence and staining were performed in an area protected from light.
5.2.8

Hydrogel Synthesis
Hydrogel precursor solutions containing a total of 20% wt. polymer (17 % MW

20,000 and 3 % MW 1000) were prepared as summarized in Chapter 3. Prior to cell
culture, hydrogels were functionalized via EDC/Sulfo-NHS chemistry as previously
described48 using collagen type I in place of fibronectin.
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5.3

5.3.1

Results

Human Skeletal Myoblast Controls
Before beginning experiments utilizing hASCs, human skeletal myoblasts

(HSkMs) were cultured to optimize primers and the MYOD antibody. Human SkMs were
utilized as a positive control for RT-PCR analysis. Primers for desmin, myogenin, mf5,
myf5, mhc, and myod were designed for these experiments. MYOD, myogenin, myf5 and
myf6 are transcription factors belonging to the myogenic regulatory factor (MRF)
family.252 This family of basic helix-loop-helix transcription factors are only expressed in
skeletal muscle and so are considered master regulators of skeletal myogenesis.253 The
housekeeping gene gapdh was used as a control for the integrity of the cDNA from
samples. The cDNA synthesized from HSkM RNA expressed each of these genes as
identified by the bands depicted in (Figure 5-3). The single bands for each gene
corresponded to the appropriate product size indicating these primers were sufficient to
identify expression of these genes.
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Figure 5-3: RT-PCR of HSkMs expressing myogenic markers. Human skeletal
myoblasts show expression of the myogenic genes desmin, myogenin, myf5, myf6,
myh6, myh, and myod. Primers were optimized at 60 °C for 35 cycles.

Human SkMS were also utilized to optimize antibody dilutions of the MYOD
antibody. The dilutions tested were 1:100, 1:200, 1:400, 1:500, and 1:1000 as seen in
(Figure 5-4). Exposure corrections had to be applied to visualize the antibody at the
1:500 and 1:1000 dilutions. The 1:400 dilution did not need exposure corrections;
however, the images are much darker compared to the lower dilutions. Due to this, the
dilution of 1:200 was chosen as the optimal dilution. Phalloidin stain was also utilized to
visualize the morphology of the cytoskeleton. The HSkMs exhibit analigned,
multinucleated morphology. This morphology is the ideal goal sought in hASC myogenic
differentiation. In addition, DAPI was used to visualize cell nuclei. From the overlay
images, we can see MYOD is localized to the cell nuclei og fully differentiated cells.
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Figure 5-4: Immunofluorescence of HSkMs using the antibody anti-MYOD and
phalloidin. The immunofluorescence shows MYOD localized in the cell nuclei
(green) of all cells. The phalloidin staining the f-actin filaments shows a highly
aligned morphology. From these images a 1:200 dilution of MYOD was chosen.

5.3.2

Culture of hASCs in Differentiation Media Alone
Human ASC’s were initially cultured in Myo B, Myo C, and CCM (used as a

negative control) for 2, 4, and 6 weeks on standard tissue culture treated polystyrene 24
well plates. However, after initial analysis, it was found 2 and 4 weeks were not sufficient
time points for detecting the expression of multiple myogenic markers and therefore is
not shown. At 6 weeks RNA was collected from all samples and cDNA was synthesized.
After gel electrophoresis it was determined that hASCs cultured in Myo B and Myo C
expressed the genes desmin, myogenin, myf6, and mhc. However, the negative control
showed expression of these genes as well. The absence of myf 5 and myod expression
indicate there is not mature skeletal muscle differentiation taking place as the expression
of one or the other is required for skeletal muscle differentiation.253

100
Immunofluorescence using antibodies against Myod and Myosin were utilized to
qualitatively evaluate protein expression in the samples. The hASCs that were only
exposed to biochemical factors via media did not express any Myod indicating no
definitive myogenic differentiation. Cells cultured in the different medias did exhibit
myosin expression. You can see in (Figure 5-5) that hASCs cultured in Myo C media
show an aligned morphology with thick bands of myosin expression. While cells cultured
in Myo B express myosin, you can see the morphology is circular which is not indicative
of myoblast morphology. The results from RT-PCR and immunofluorescence of those
cells cultured in different medias do not show definitive myogenic differentiation and
therefore we hypothesized would require the introduction of additional biomolecules to
attempt to drive differentiation towards a myogenic lineage.

Figure 5-5: Immunofluorescence of hASCs using anti-myosin (skeletal fast)
antibody. Myosin expression (orange) shows an aligned morphology in cells cultured
in Myo C media.
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5.3.3

Culture of hASCs in Differentiation Media on Protein Coated Plates
Non-treated polystyrene tissue culture plates were coated with collagen type I,

fibronectin, and laminin at a concentration of 0.02 µg/µL for all proteins. Each protein
was diluted in PBS to coat each well and plates were kept at 4 °C for 24 hours before
blocking each well with BSA to prevent nonspecific binding. Human ASCs were then
seeded on plates coated with collagen type I, fibronectin, laminin, and tissue culture
treated wells as a control. Cells were cultured in either Myo B, Myo C, or CCM for 6
weeks. This gave 12 different sample combinations to analyze. It was determined that the
best course of action was to collect RNA at 6 weeks and evaluate expression of myogenic
genes through RT-PCR to determine which combination of media and ECM protein is the
most effective for promoting myogenic differentiation.
Through RT-PCR analysis we determined that Myo C was a more efficient
differentiation media compared to Myo B. This is due to the brighter band expression in
Myo C samples and the consistency between samples. While all media and protein
combinations expressed desmin, myogenin, myf6, and mhc, there was still no expression
of myf5 or myod (Figure 5-6).
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Figure 5-6: RT-PCR of hASCs cultured in different media and protein combinations.
End point PCR shows expression of early myogenic markers in all samples. However,
Myo B samples appear to have the lowest expression levels. No samples express myf5
or myod.
Based on the immunofluorescence images from hASCs cultured in only media
along with RT-PCR results, i Myo C was determined to be the more effective media for
inducing myogenic differentiation of hASCs with no noticeable differences observed in
the expression profile of cells cultured in Myo C on the three different protein coated
surfaces. Therefore, for ease and affordability collagen type I was selected for further
studies.
5.3.4

Introduction of 5’-azacytidine to Myo C Media
The combination of Myo C media and collagen type I did not yield expression of

myod or myf5. In attempt to enhance myogenic differentiation and observe expression of
all four MRF transcription factors, 5-azacytidine, a DNA methylation inhibitor, was
added at a 10 µM concentration for 24 hours249 in Myo C media (referred to as Aza C).
Cells were also cultured on collagen type I coated plates. The combination of 5-
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azacytidine in Myo C for 24 hours followed by 6 weeks of culture in Myo C on collage
type I coated plates led to the expression of all four MRFs in hASCs as seen in (Figure 57). The expression of myf5 is consistent across all Aza C samples while myod is only
expressed slightly in one sample. This could be due to where the cells where in the cell
cycle, as this has been shown to affect which gene(s) are expressed during myogenesis.254

Figure 5-7: RT-PCR of hASCs cultured in 5-azacytidine. Human ASCs that were
exposed to 5-azacytidine for 24 hours on collagen coated plates with Myo C media for
a total time of 6 weeks express the master regulator myf5 consistently in triplicate.

In addition, hASCs cultured in Aza C on collagen type I coated plates were the
first to show expression of MYOD through immunofluorescence (Figure 5-8). The
expression is not isolated to the nuclei that was seen in human skeletal myoblast controls
however, they are expressing MYOD which is one of the master regulators of
myogenesis. This shows that myogenic differentiation is taking place in hASCs when
they are cultured on collagen type I coated plates in Aza C media.
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Figure 5-8: MYOD immunofluorescence of hASCs exposed to 5-azacytidine. After
24-hour exposure to 5-azacytidine followed by 6 weeks in Myo C media on collagen
coated plates, MYOD (orange) and Dapi (blue) stain were used to determine if
MYOD protein was expressed. The overlay image shows MYOD expression
localizing around the cell nuclei. This was the first set of samples that demonstrated
any MYOD expression, indicating it is the more efficient differentiation protocol.
5.3.5

Myogenic Differentiation of hASCs cultured on 17:3 PEGDMA

hydrogels
The 17:3 PEGDMA hydrogels that have an elastic modulus of 8-10 kPa were
surface modified and coated with collagen type I. Human ASCs were seeded on the
surface of 17:3 hydrogels and cultured for a total time of 2 weeks. Cells were initially
seeded in CCM, but at the 24-hour timepoint CCM was replaced with Myo C media
that contained 5-azacytidine. Cells were cultured in Myo C + 5-azacytidine for 24
hours and then switched to regular Myo C media for the remainder of the 2 weeks. At
two weeks, cells began to peel off of the hydrogel surface due to over-confluences, so
RNA was collected and cells were fixed for immunofluorescence.
Gene expression was analyzed in duplicates using RT-PCR. There was no
expression of early myogenic markers in samples cultured on 17:3 collagen coated
hydrogels. There was expression of later myogenic markers including myf6, mhc, and
the master regulator myod (Figure 5-9). The expression of myod in samples cultured
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on hydrogels is greater compared to those on tissue culture plates that underwent the
same surface modification and were exposed to the same media components.

Figure 5-9: RT-PCR of myogenic markers that are expressed when hASCs are
cultured on 17:3 PEGDMA hydrogels. These hydrogels were surface modified and
coated with collagen type I. Cells were exposed to 5-azacytidine for 24 hours then
cultured in Myo C media for 2 weeks. The hASCs only expressed late myogenic
markers.
Immunofluorescence was also utilized to visualize the expression of the myogenic
proteins myosin and myod. The hASCs exhibited myosin expression and showed an
aligned myosin morphology in the immunofluorescence images (Figure 5-10).

Figure 5-10: Immunofluorescence images of the myosin protein. The white circle
highlights an area with an increase in the aligned morphology of myosin that is
associated with myogenic differentiation. Scalebars: 1000 µm.
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Most notable of the immunofluorescence that was performed is the expression of
MYOD in hASCs cultured on the collagen coated hydrogels. When hASCs were cultured
on tissue culture plates for 6 weeks after exposure to 5-azacytidine there is very little
MYOD expressed in the immunofluorescence images (Figure 5-8). Here, after only 2
weeks after exposure to 5-azacytidine there is a much more MYOD protein being
expressed (Figure 5-11). Also, of note is the localization of MYOD in cell nuclei that is
beginning to take place, which is indicative of myoblast formation. This is seen in the
overlay image by the appearance of purple coloring. The purple color is created due to
the blue from the Dapi stain and the orange from the MYOD antibody.

Figure 5-11: Immunofluorescence using the anti-MYOD antibody to qualitatively
evaluate protein expression. You can see much higher levels of MYOD expression
compared to cells cultured on tissue culture. In addition, the overlay image of Dapi
and MYOD shows MYOD localizing in cell nuclei which is indicative of myoblast
formation. Scalebars: 1000 µm.
Finally, hASCs that were cultured on the 17:3 collagen coated hydrogels were
stained with phalloidin and Dapi. This allows for the visualization of the cytoskeleton of
cells and their morphology. From the phalloidin stain (Figure 5-12) we can see a highly
aligned morphology with the cytoskeletons beginning to compact and create a fibrous
morphology. This is not a morphology typical of undifferentiated hASCs. It is very
similar to the morphology of human skeletal myoblasts as shown in Figure 5-4. The
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overlay image shows multinucleation taking place as well, which is typical of human
skeletal myoblasts.

Figure 5-12: Phalloidin staining of the f-actin filaments shows the cytoskeleton
morphology to be compact and highly aligned. The overlay image depicts
multinucleation of cells beginning to take place. Scalebars: 1000 µm.

5.4

Discussion

This work focused on optimizing myogenic differentiation conditions utilizing
different combination of biomolecules. We utilized two media recipes previously
reported in literature to promote myogenic differentiation in combination with three ECM
proteins in an attempt to enhance differentiation efficiency. Human ASCs did not express
myf5 or myod when cultured in myogenic media alone or when combined with one of the
three selected ECM proteins. Once 5-azacytidine was introduced to Myo C media,
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however, cells that were cultured on collagen type I coated plates began expressing these
master regulators of myogenesis.
When hASCs were cultured on collagen coated 17:3 hydrogels an increase in
expression of MYOD, one of the master regulators of myogenesis, demonstrated using
RT-PCR was observed. In addition, there was no expression of early myogenic markers,
only late markers were expressed. In addition, we see an increase in MYOD protein
expression as seen through immunofluorescence images. The MYOD is also beginning to
show localization in the cell nuclei, which is typical of fully differentiated human skeletal
myoblasts. Phalloidin and Dapi staining also shows a cell morphology and
multinucleation similar to that seen in human myoblast samples. It appears that when
cultured on 17:3 PEGDMA hydrogels, hASCs show an increase in myogenic
differentiation potential. The cells were exposed to the same surface ECM protein,
collagen type I, and the same concentration of 5-azacytidine, yet when cultured on
PEGDMA hydrogels at only 2 weeks we see greater expression of master regulators and
morphologies typically of myoblasts.
There is still more to be done in order to further enhance myogenic
differentiation of hASCs through the use of chemical and physical cues. We show that
biochemical stimulation alone may not be enough to fully differentiate hASCs towards a
myogenic lineage. However, when the only factor that was changed was surface elasticity
(comparing the hydrogel to tissue culture plates) we see a dramatic difference in
differentiation potential. This indicates that physical factors such as surface elasticity has
a synergistic effect with biochemical stimulation in terms of myogenic differentiation
potential. Future work will begin to incorporate other extracellular with Aza C media in
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order to determine if combining biomolecules with other external factors will enhance
differentiation further than what we show in these experiments. Optimizing myogenic
conditions is the first step in being able to create functional tissue patches to treat muscle
loss and damage.

CONCLUSIONS AND FUTURE DIRECTIONS

6.1

Research Summary

There are numerous factors that can influence stem cell fate. The environmental
stimulus, chromatin modifiers, signal transduction molecules, and transcription factors all
impact the ultimate decision the cell makes. Modification to even one of these factors
will change the genes expressed and the decision to continue self-renewal or differentiate.
My Ph.D. project has specifically focused on investigating how changes in environmental
stimuli influences cell fate by utilizing a tailorable PEGDMA hydrogel platform.
Through the tailorability of the PEGDMA hydrogel platform, I have been able to evaluate
environmental stimuli such as: surface elasticity, surface topography, and the
incorporation of biochemical factors and their effect on stem cell fate.
In Chapter 3 PEGDMA hydrogel elasticity was altered by changing the ratio of
high molecular weight polymer (MW 20,000) to low molecular weight polymer (MW
1000) while keeping the total percent polymer constant at 20 % w/w. A “soft” hydrogel
with elasticity of 8-10 kPa and a “stiff” hydrogel with elasticity of 50-60 kPa were
utilized as a scaffold for hMSCs and compared to a standard polystyrene tissue culture
plate used as the control. Human MSCs attached to the hydrogels and remained viable
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after seeding, demonstrating biocompatibility. However, after 72 hours, cell density on
stiff hydrogels was much lower when compared to tissue culture controls, indicating a
decrease in proliferation rates, confirmed by an alamarBlue™ assay. When cultured in
maintenance media (CCM) hMSCs cultured on all three surfaces maintained their
multipotent potential as depicted through qRT-PCR. Osteogenic and adipogenic
differentiation of cells cultured on soft and stiff hydrogels was also analyzed. There was a
significant difference in expression of early osteogenic markers when cells were cultured
on stiff hydrogels. This could be an indication of less efficient differentiation potential, or
that cells were further along in differentiation than those on tissue culture or soft
hydrogels. These studies demonstrate that the elasticity adult stem cells are cultured on
influences their behavior and cell state, indicating the potential for using this hydrogel
platform to create a controlled environment for tissue engineering applications.
Chapter 4 focused on the development of PEGDMA hydrogel platforms with
multiscale porosity through flash freezing and lyophilization. Hydrogels of varying
thickness, polymer blend, and drying method were evaluated in this work. Environmental
scanning electron microscopy (ESEM) imaging of hydrogels in a hydrated state
demonstrated that freeze-dry lyophilization altered the hydrogel architecture when
compared to air-dried controls. This change in architecture created pores of varying sizes
leading to polymers with multiscale porosity. Freeze-dry lyophilization also caused a
change in shear elastic modulus when compared to their air-dried counterparts. While
hydrogel topography and elastic moduli were altered by drying method, lyophilized
samples exhibited the same absence of degradation in media as air-dried samples. Human
ASCs were cultured on lyophilized and air-dried hydrogels of the same PEGDMA blend
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and both demonstrated biocompatibility regardless of drying method. By altering the
porosity and therefore topography of the PEGDMA hydrogels through drying method,
this gives more flexibility and tailorability for potential use for tissue engineering
scaffolds.
Lastly, the work in Chapter 5 evaluated the efficiency of myogenic
differentiation of hASCs through extracellular exposure to different biomolecules. By
altering the components of culture medias and by surface coating the plates they were
cultured on with different extracellular proteins, we observed differences in
differentiation potential. Exposure to culture media alone led to differences in myosin
expression in hASCs. Those cultured in Myo C demonstrated an aligned morphology,
like what would be seen in human skeletal myoblast cells. When hASCs were cultured in
differentiation medias combined with different surface proteins, expression of several
early myogenic markers was expressed. However, the master regulators myf5 and myod
were still not expressed. The methylation inhibitor 5-azacytidine was added into Myo C
media for 24 hours before being switched to normal Myo C media. The incorporation of
this methylation inhibitor led to the expression of myf5 and myod in hASCs after 6 weeks,
indicating myogenic differentiation. When biochemical factors were combined with
PEGDMA hydrogels that have an elasticity similar to muscle tissue,48 we saw a dramatic
increase in MYOD expression in a much shorter time frame. This demonstrates that all
environmental stimuli influence cell fate and combinations of various extracellular cues
should be investigated further.
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6.2

Future Directions

The ultimate goal of this work was to gain a better understanding of cell fate as a
function of cell environment. From this work a tailorable PEGDMA hydrogel platform
that allows for more in-depth cell-material studies has been created. By altering the
properties of the hydrogel such as elasticity, surface topography, and different
biomolecules that can be attached to the surface, I was able to create the ideal
environment to study how to best control cell fate. In addition, utilizing different
biomolecules we were able to differentiate hASCs towards a myogenic lineage, opening
up more areas of possible research in the future. In Chapter 3 it is shown that hydrogel
elasticity influences cell proliferation and osteogenic differentiation potential. This
preliminary work has led to a possible future project where the lab could further explore
why stiffer hydrogel have a significant influence on stem cell differentiation. Quantitative
RT-PCR of middle and late differentiation markers would distinguish if the decrease was
due to cells being further differentiated or if the change is a decrease in differentiation
efficiency.
The multiscale porosity PEGDMA hydrogels discussed in Chapter 4
demonstrated hASC biocompatibility and retain their innate hydrogel properties. This
offers an additional way to tailor PEGDMA hydrogels and explore stem cell
multipotency, proliferation rates, and differentiation potential on. Since the work in
Chapter 3 demonstrated that elasticity influences cell behavior, studies should be
conducted on how this change in network architecture affects cell state. We know that
drying method alters the shear elastic modulus, thus it is likely cells would behave
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differently on lyophilized and air-dried scaffolds. In addition, it has been previously been
shown by other groups that pore size and matrix architecture influence cell proliferation
and differentiation ability.255–259 Therefore, the change in architecture seen through
different drying methods will likely initiate a change in cell behavior. Since osteogenesis
and adipogenesis in adult stem cells is highly characterized, these routes of differentiation
potential should be explored on the multiscale PEGDMA scaffolds.
Myogenesis of hASCs discussed in Chapter 5 only utilizes biomolecules through
media and surface coating standard non-treated tissue culture plates. Culturing the cells
exposed to different biomolecules on the PEGDMA hydrogels of varying elasticity would
be the next step. Since the “soft” (17:3) hydrogels have an elasticity of 8-10 kPa it is
hypothesized that this would enhance myogenic differentiation. This is due to skeletal
muscle tissue having an elastic modulus of ~10-11 kPa.235 There are no universal
myogenic differentiation medias so utilizing the extracellular environment would be an
ideal option to further explore the differentiation potential of hASCs. This work has
shown that utilizing different biomolecules can stimulate hASC differentiation towards a
myogenic lineage. This opens up another area of research that can be explored in terms of
cell-material interactions.
6.3

Conclusions

Despite the abundance of research in this field, the interactions between stem cells
and the external environment created using biomaterial substrates are not well
understood. This research is helping to bridge this knowledge gap utilizing PEGDMA
hydrogels with adult stem cells. The PEGDMA hydrogels that our lab utilizes can be
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produced in large quantities, and they are an affordable scaffolding option. In addition,
they can easily be tailored as demonstrated throughout this research. This work has
demonstrated that substrate elasticity alone can influence stem cell behavior with altering
attachment, proliferation, and differentiation potential. Utilizing freeze-dry lyophilization
as a post-processing drying method, PEGDMA hydrogels of multiscale porosity were
created. Through ESEM imaging it was shown that this changes the hydrogel architecture
and surface morphology. This provides a novel PEDGMA platform that can be used to
investigate how surface topography influences cell fate. In addition, to our knowledge,
this was the first time that PEGDMA hydrogels were imaged in the hydrated state using
ESEM. Finally, we show that hASCs myogenic differentiation potential is influenced by
various biomolecules. While there are a few myogenic differentiation medias reported in
literature, when used alone, we could not confirm hASC differentiation. By combing
these medias with different extracellular matrix proteins and the methylation inhibitor 5azacytidine, we were able to confirm myogenic differentiation through RT-PCR.
The long-term goal of this work is to create affordable, clinically relevant
scaffolds that can reliably control stem cell fate via external stimuli. This research
supports this goal in providing an understanding of how elasticity and biomolecules
influence adult stem cell differentiation potential. In addition, the creation of hydrogels
with multiscale porosity yields another way in which this platform can be tailored to
create an environment to direct stem cell fate. This project has opened several new
opportunities for research that can move the field of tissue engineering forward through
the pursuit of creating a biomaterial scaffold that can control stem cell fate.

NATURAL AND HYBRID HYDROGELS IN-DEPTH DISCUSSION
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A.1

Natural Hydrogels:

Hydrogels synthesized from natural polymers are frequently used because they
are components of, or have macromolecular properties that are similar to the extracellular
matrix.31,260 Collagen, fibrin, hyaluronate, alginate, and chitosan are synthetic polymers
that have been used to create hydrogels in hopes to revolutionize the tissue engineering
field.139 Collagen is one of the main component of the extracellular matrix of mammalian
tissues such as skin, bone, cartilage, tendon and ligaments.261 Collagen has been used for
several tissue engineering application including for endothelial tissue scaffolds and the
formation of porous, spongy scaffolds.31,261 One issue with utilizing collagen is the
potential antigenicity.261 Fibrin is another natural polymer used in tissue engineering.
Fibrin is advantageous in that scaffolds can be created using the patient’s own blood
eliminating the chance of immune response to the scaffold.262 It has been studied to be a
scaffold for adipose tissue, muscle, skin, articular cartilage, ocular tissue, and
cardiovascular purposes.261,262 The main concern with fibrin for tissue engineering
purposes is that it undergoes enzymatic degradation and it has poor mechanical
strength.261,262 Another commonly used natural polymer in tissue engineering is
hyaluronic acid (HA). Hyaluronic acid is a polysaccharide found naturally in the
extracellular matrix which is one reason it is a popular material in tissue
engineering.31,261,263 However, hyaluronic acid can be degraded by hyaluronidase,
naturally found in tissues, and suffers from low mechanical strength.261,264,265 Alginate
has been studied in regenerative medicine for applications such as cell encapsulation,
drug stabilization, transplantation of chondrocytes, hepatocytes, and islets of Langerhans
117
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to treat diabetes.139,266 Unfortunately it is hard to control swelling behavior and they tend
to rapidly degrade due to ion loss.139,267 The final natural polymer of note is chitosan.
Chitosan has a high molecular weight and is the second most abundant biopolymer found
in crustacean shells and fungi cell walls.268 It is structurally similar to
glycosaminoglycans and has been studied for bone regeneration, articular cartilage repair,
and most notably for wound dressings.261,268,269 This information is summarized in Table
A-1. The main concern with natural polymers is the source. Some of these materials are
harvested from other species and there is concern for an immune response using materials
from a different origin.132,139
A.2

Hybrid Hydrogels:

Synthetic/natural hybrid polymers or semi-synthetic polymers, incorporates
desirable features from both types of polymers. Synthetic hydrogels are typically passive
scaffolds and biologically inert while natural polymers typically aid in the regulation of
cell responses having critical biologic functions.145 Thus, combining the two yields a
bioactive hydrogel scaffold. These hybrid hydrogels create bioactive hydrogels without a
complicated synthesis for bioconjugation. The natural extracellular matrix can be thought
of as a hybrid material with the rigid structural components interacting and support soft
biomolecules like cells, signaling factors, and enzymes.270 The goal of any tissue
scaffold is to mimic the natural cell environment as closely as possible making hybrid
polymer scaffolds an attractive approach. Combining the properties from the synthetic
and natural polymers has the potential to increase mechanical stability, provide a better
architecture, and more favorable chemical compositions.270
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Table A-1. An overview of natural polymers used in making hydrogel biomaterials.
Polymer
Uses
Disadvantages
Advantages
alginate

Cell

Degrades

Successful

encapsulation,

uncontrollably and

encapsulation and

drug

unpredictably through

immunoprotection of

stabilization,

loss of divalent ions

transplanted cells

transplantation

into surrounding

of chondrocytes,

medium

hepatocytes, and
islets of
Langerhans
chitosan

Rigid tissue

Degraded by

High molecular

replacements

lysozyme

weight, second most
abundant natural
biopolymer

collagen

Fiber and space

Degraded by

Excellent

filling

metalloproteases

biocompatibility and
biodegradability

Hyaluronan

Wound healing

Degraded by

Only non-sulfated

hyaluronidase

GAG and major
constituent of ECM

fibrin

Engineer tissues

Limited in mechanical

Harvested from

with skeletal

strength

patient’s blood

muscle cells,

removing chance of

smooth muscle

immune

cells and

response/rejection

chondrocytes

HYDROGELS IN BIOMANUFACTURING
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There is a growing list of tissues that have the potential to be successfully
engineered in the near future. This is largely due to the recent advancements in stem cell
biology and the recognition of the unique biological properties of stem cells.271 For tissue
regeneration to become a clinical reality these materials need to be producible on a large
scale. This drive for the need of large-scale production leads us to the field of advanced
biomanufacturing. The field of advanced biomanufacturing relies on the reproducible and
efficient generation of biocompatible materials for the study of cellular properties and
directed differentiation as well as the creation of clinically-relevant tissues for therapeutic
applications.48 Previously, tissues such as the skin, cornea, mucosal membrane (epithelial
surfaces), and skeletal tissues have been successfully engineered using stem cell
strategies. Studies are being conducted using stem cells in engineering tissues such as the
heart muscle, pancreas, liver, cartilage, and bone among others.271 There are numerous
techniques in biomanufacturing to achieve the goal of tissue replacement and
regeneration. These techniques include electrospinning, freeze-drying, melt molding,
membrane lamination, gas foaming, and 3-D printing.48,272 These processes can be too
complex or expensive for large-scale productions, so there is a need to develop more
accessible ways to manufacture the materials.48
There are two fundamental approaches that can be used for biomanufacturing to
improve tissue function: the bottom-up approach and top-down approach.273 The bottomup approach relies on self-assembly or directed-assembly of a scaffold from smaller
components. A common characteristic of this approach is micro- or even nanoscale
structures assembling into macroscopic objects.272 The ability of the cell aggregates to
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fuse is based on the concept of tissue fluidity. The drawback to this approach is that not
all cell types are able to produce sufficient extracellular matrix, form cell-cell junctions,
or migrate.273 The top-down approach is the most common strategy for tissue
engineering, and the one this review will focus on. The top-down approach is a scaffoldbased approach.273 In this approach cells are seeded on a scaffold that is not only
biocompatible, but biodegradable as well. The cells are expected to proliferate in the
scaffold and create their own extracellular matrix.272 The success of this method is
dependent on the materials and the manufacturing processes.273 Hydrogel scaffolds
tailored for stem cell differentiation is of particular interest in biomanufacturing for tissue
replacement and regeneration.
Stem cells have the ability to self-renew and maintain at least one differentiated
tissue type throughout the lifespan of the organism.274 Stem cell development is a very
complex process. There has to be a precise balance among many events of the cell
including self-renewal, differentiation, apoptosis, and migration.77 Mesenchymal stem
cells are undifferentiated multipotent cells that have the ability to differentiate into
multiple tissues of mesenchymal origin in response to the appropriate signals.275 The
unique properties of self-renewal and differentiation make stem cells ideal for the use of
large scale production for tissue engineering.48
Hydrogels constructed from synthetic polymers seeded with stem cells offers a
possible solution to the need for large scale biomanufacturing in tissue engineering. The
tailorable nature of hydrogel scaffolds can provide stem cells with the appropriate cues
and cellular microenvironment for differentiation and proliferation.276 Hydrogels provide
a three-dimensional environment for stem cells. 3-D environments have been shown to
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enhance osteogenic, hematopoietic, neural, and chondrogenic differentiation. By altering
the substrate properties, surface interactions, scaffold degradation rate, or the
microenvironment of the hydrogel can directly influence the behavior of stem cells.277
For example, the elasticity of hydrogels can be widely varied. This means the strain
environment within the hydrogels can provide the appropriate mechanical stimuli for
stem cell differentiation towards a particular lineage.278 The optimum elastic modulus
depends on the stem cell type and the lineage in which it is being directed.279 This is just
one modification that can influence the differentiation of stem cells. Other modifications
in the hydrogel environment have the potential to affect stem cell lineage as well.
Hydrogels seeded with stem cells undoubtedly provides a platform of great promise of
large-scale manufacturing for tissue engineering.
The large-scale biomanufacturing of hydrogels can be accomplished by
stereolithographic and inkjet printing processes.273 Stereolithography is one of the most
developed and most accurate forms of rapid prototyping.280 The conventional
stereolithography apparatus uses ultraviolet light to solidify photosensitive polymers.281
The three-dimensional structures can be precisely fabricated in a layer-by-layer approach.
It is principally based on the spatially controlled solidification of a liquid photopolymerisable resin upon illumination.280 Stereolithography allows for the creation of
three-dimensional hydrogel structures with feature sizes ranging from micrometers to
centimeters, with the option of incorporating matrices with varied properties and
structure.282 Poly(ethylene glycol) (PEG) hydrogels produced by stereolithography has
been discussed in multiple studies.273,280,283 PEG hydrogels (and others similar to PEG)
undergo UV polymerization at low light intensities for short periods of time with low
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organic solvent levels so the stereolithographic process can be carried out in the presence
of cells, such as stem cells seeded in the polymer matrix.273b
Inkjet printing is a noncontact printing technology that uses tiny ink drops to
reproduce digital patterns, and is highly biocompatible with biological systems.284 Inkjet
printing allows for rapid and inexpensive printing of cells, materials and other protein
molecules.285 For manufacturing of hydrogels using inkjet printing, the material jetting
processes emit a stream of hydrogel microparticles to an exact co-ordinate. The process
of hydrogel formation is based on the deposition of bio-ink particles in well-defined
topological patterns into bio-paper sheets of biocompatible gels. The construct is then
transferred to a bioreactor to fuse the bio-ink particles.273 PEG and PEG-peptide
hydrogels have been synthesized using this process and shown promising results with
stem cell differentiation.284
Large-scale biomanufacturing in tissue engineering poses challenges that need to
be overcome for the clinical availability of tissue repair and regeneration. The
customizability of hydrogels combined with the unique self-renewal and differentiation
properties of stem cells shows promise as a solution for the challenges facing tissue
engineering. Large-scale biomanufacturing of these hydrogels seeded with stem cells
could be made possible in the near future with advancements in rapid prototyping
processes such as stereolithography and inkjet bioprinting. Through the combined efforts
of cell biologists, engineers, material scientists, mathematicians, geneticists, and
clinicians, the successful large-scale biomanufacturing of hydrogels is on the horizon.191

SUPPLEMENTAL INFORMATION FOR CHAPTER 3
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C.1

RNA Concentrations

Table C-2. Concentration of RNA used for qRT-PCR analysis of multipotency,
osteogenic, and adipogenic markers. Reprinted with permission from Oxford Academic.
Cell Type
Undifferentiated

RNA Concentration
0.150 μg

MSCs
MSC-Derived

0.150 μg

Adipocytes
MSC-Derived

0.050 μg

Osteocytes
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C.2

Primer Sequences

Table C-3. Primer sequences utilized in qRT-PCR. Reprinted with permission from
Taylor & Francis.
Specificity
gapdh

Housekeeping
gene

sox2

Undifferentiated
hMSCs marker

runx2

Osteogenic
marker

alp

Osteogenic
marker

ppar- γ Adipogenic
marker
srebp-1c Adipogenic
marker

Primer sequence (5’ – 3’)
F:
AGGGCTGCTTTTAACTCTGGT
R:
CCCCACTTGATTTTGGAGGGA
F:
GGCAGCTACAGCATGATGCAGAGC
R: CTGGTCATGGAGTTGTACTGCAGG
F:
CTCACTACCACACCTACCTG
R:
TCAATATGGTCGCCAAACAGATTC
F:
CTAACTCCTTAGTGCCAGAG
R:
CATGATGACATTCTTAGCCAC
F:
GCTGTTATGGGTGAAACTCTG
R:
ATAAGGTGGAGATGCAGGTTC
F:
CTCTTGAAGCCTTCCTGAG
R:
GCACTGACTCTTCCTTGAT

SUPPLEMENTAL INFORMATION FOR CHAPTER 4
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D.1

Pore Size Estimation Using ImageJ Software

Average diameter of induced micropores as a function of polymer blend, drying
method, and sample condition, calculated from ESEM images using ImageJ software.
Samples without a reported average induced micropore size were samples that did not
have visible pores. The average induced pore size was generated from the average
measured pore size from ~15-20 images from 1 sample of each sample set.
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Table D-4. Average pore size as a function of polymer blend, drying method, hydrogel
state, and thickness. Reprinted with permission from Taylor & Francis.
PEGDMA Hydrogel
Blends 20 kDa : 1 kDa
17:3
17:3
17:3
17:3
17:3
17:3
17:3
17:3
15:5
15:5
15:5
15:5
15:5
15:5
15:5
15:5
10:10
10:10
10:10
10:10
10:10
10:10
10:10
10:10
0:20
0:20
0:20
0:20
0:20
0:20
0:20
0:20

Drying
Method
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO
AD
LYO

Hydrogel
State
dry
dry
dry
dry
hydrated
hydrated
hydrated
hydrated
dry
dry
dry
dry
hydrated
hydrated
hydrated
hydrated
dry
dry
dry
dry
hydrated
hydrated
hydrated
hydrated
dry
dry
dry
dry
hydrated
hydrated
hydrated
hydrated

Thickness
(mm)
1
1
7
7
1
1
7
7
1
1
7
7
1
1
7
7
1
1
7
7
1
1
7
7
1
1
7
7
1
1
7
7

Average Induced
Micropore Size (μm)
24.94 ± 11.44
38.65 ± 27.92
8.43 ± 8.74
29.17 ± 20.50
27. 53 ± 57.88
20.74 ± 15.56
6.82 ± 7.88
15.21 ± 12.22
14.86 ± 7.41
7.26 ± 5.47
39.70 ± 63.26
9.08 ± 7.01
7.89 ± 9.04
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